康宁corning 431364 CAP,ERLENMEYER FLASK,2L,FLAT,P
48mm密封盖(用于2L三角瓶) 1个/包 24包/箱 2116.14
分类目录归档:生化试剂
康宁corning 4134 ONE RELOAD-1000XT NAT EXT LENGTH TIPS VACCUM FORMED 8 DECKS,768/768 96个/盒,8盒/包
康宁corning 4134 ONE RELOAD-1000XT NAT EXT LENGTH TIPS VACCUM FORMED 8 DECKS,768/768 96个/盒,8盒/包 1包/箱 488.2
康宁corning 43923 96 Well White Polystyrene High Bind Stripwell Microplate, 25 per Bag, without Lid, Nonsterile ,25/PK,4PK/cs 25个/包
康宁corning 43923 96 Well White Polystyrene High Bind Stripwell Microplate, 25 per Bag, without Lid, Nonsterile ,25/PK,4PK/cs 25个/包 4包/箱 4786.36
水溶性维生素
产品编号 | 产品名称 | 产品规格 | 产品等级 | 产品价格 |
203-00851 | Thiamin Hydrochloride 维生素B1 | 1g | - | - |
201-00852 | Thiamin Hydrochloride 维生素B1 | 25g | - | - |
209-00853 | Thiamin Hydrochloride 维生素B1 | 100g | - | - |
205-00855 | Thiamin Hydrochloride 维生素B1 | 500g | - | - |
185-00861 | Riboflavin Tetrabutyrate 核黄素四丁酸酯 | 5g | - | - |
183-00862 | Riboflavin Tetrabutyrate 核黄素四丁酸酯 | 25g | - | - |
142-01232 | Nicotinic Acid 烟酸 | 25g | - | - |
144-01231 | Nicotinic Acid 烟酸 | 100g | - | - |
146-01235 | Nicotinic Acid 烟酸 | 500g | - | - |
208-00921 | (±)-1,2-Dithiolane-3-valeric Acid (±)硫辛酸 | 1g | - | - |
204-00923 | (±)-1,2-Dithiolane-3-valeric Acid (±)硫辛酸 | 10g | - | - |
062-01801 | Folic Acid 叶酸 | 1g | - | - |
060-01802 | Folic Acid 叶酸 | 25g | - | - |
169-12952 | D(+)-Panthenol D-泛醇 | 25g | - | - |
163-12955 | D(+)-Panthenol D-泛醇 | 500g | - | - |
031-14161 | Calcium(+)-Pantothenate (+)-泛酸钙 | 1g | - | - |
039-14162 | Calcium(+)-Pantothenate (+)-泛酸钙 | 25g | - | - |
033-14165 | Calcium(+)-Pantothenate (+)-泛酸钙 | 500g | - | - |
198-05651 | Sodium(+)-Pantothenate (+)-泛酸钠 | 1g | - | - |
196-05652 | Sodium(+)-Pantothenate (+)-泛酸钠 | 25g | - | - |
165-05401 | Pyridoxine Hydrochloride 盐酸吡哆醇 | 1g | - | - |
163-05402 | Pyridoxine Hydrochloride 盐酸吡哆醇 | 25g | - | - |
161-05403 | Pyridoxine Hydrochloride 盐酸吡哆醇 | 100g | - | - |
160-23651 | Pyridoxal Hydrochloride 盐酸哆醛 | 1g | - | - |
168-23652 | Pyridoxal Hydrochloride 盐酸哆醛 | 25g | - | - |
162-23655 | Pyridoxal Hydrochloride 盐酸哆醛 | 500g | - | - |
169-20941 | Pyridoxal Phosphate Monohydrate 吡哆醛磷酸一水合物Pyridoxal Phosphate Monohydrate 吡哆醛磷酸一水合物 | 100mg | - | - |
165-20943 | Pyridoxal Phosphate Monohydrate 吡哆醛磷酸一水合物 | 1g | - | - |
163-20944 | Pyridoxal Phosphate Monohydrate 吡哆醛磷酸一水合物 | 10g | - | - |
023-08711 | (+)-Biotin (+)-生物素 | 100mg | - | - |
023-08716 | (+)-Biotin (+)-生物素 | 500mg | - | - |
029-08713 | (+)-Biotin (+)-生物素 | 1g | - | - |
021-08712 | (+)-Biotin (+)-生物素 | 5g | - | - |
027-08714 | (+)-Biotin (+)-生物素 | 10g | - | - |
220-00341 | Cyanocobalamin 氰钴维生素 | 10mg | - | - |
226-00343 | Cyanocobalamin 氰钴维生素 | 100mg | - | - |
224-00344 | Cyanocobalamin 氰钴维生素 | 1g | - | - |
220-00346 | Cyanocobalamin 氰钴维生素 | 10g | - | - |
138-14261 | Methylcobalamin 甲基维生素B12 | 100mg | - | - |
134-14263 | Methylcobalamin 甲基维生素B12 | 1g | - | - |
132-14264 | Methylcobalamin 甲基维生素B12 | 5g | - | - |
081-05631 | Hydroxocobalamin Acetate 羟钴胺 | 100mg | - | - |
087-05633 | Hydroxocobalamin Acetate 羟钴胺 | 1g | - | - |
085-05634 | Hydroxocobalamin Acetate 羟钴胺 | 5g | - | - |
062-05061 | Fursultiamine Hydrochloride(mixture of isomers) 盐酸呋喃硫胺(同分异构体混合物) | 5g | - | - |
060-05062 | Fursultiamine Hydrochloride(mixture of isomers) 盐酸呋喃硫胺(同分异构体混合物) | 25g | - | - |
012-04802 | L(+)-Ascorbic Acid L(+)-抗坏血酸 | 25g | - | - |
014-04801 | L(+)-Ascorbic Acid L(+)-抗坏血酸 | 100g | - | - |
016-04805 | L(+)-Ascorbic Acid L(+)-抗坏血酸 | 500g | - | - |
水溶性维生素
◆维生素B1
维生素B1(Thiamin Hydrochloride)
CAS No. 67-03-8 C12H17ClN4OS・HCl=337.27 纯度:98.0+%(HPLC)(脱水物换算) 可溶性溶剂:水 用途(作用):维生素B1化合物。作用于糖类的代谢。 |
◆维生素B2
核黄素四丁酸酯(Riboflavin Tetrabutyrate)
CAS No. 752-56-7 C33H44N4O10=656.73 纯度:98.0 ~ 102.0%(Absorptiometry) (乾燥後) 可溶性溶剂:氯仿 用途(作用):维生素B2化合物。作为黄素酶的辅酶作用于氧化还原反应。 |
◆维生素相关化合物
烟酸(Nicotinic Acid)
CAS No. 59-67-6 C6H5NO2=123.11 纯度:98.0+%(Titration) 可溶性溶剂:水 用途(作用):脱水酶辅酶。作用于氧化还原反应。 |
(±)硫辛酸((±)-1,2-Dithiolane-3-valeric Acid)
CAS No. 1077-28-7 C8H14O2S2=206.33 纯度:98.0+%(Titration) 可溶性溶剂:氯化铵-稀氨水溶液 用途(作用):类脂酸化合物。作为辅酶参与丙酮酸和α-酮戊二酸的氧化脱碳反应,生成乙酰辅酶A,促进能量代谢。 |
叶酸(Folic Acid)
CAS No. 59-30-3 C19H19N7O6=441.40 纯度:98.0 ~ 102.0%(Absorptiometry) (脱水物换算) 可溶性溶媒:氢氧化钠溶液 用途(作用):作用于核酸代谢。 |
◆维生素B5相关化合物
D-泛醇(D(+)-Panthenol)
CAS No. 81-13-0 C9H19NO4=205.25 纯度:98.0+%(Titration) 可溶性溶剂:水 用途(作用):B族维生素化合物。容易吸收的泛醇会在生物体内被氧化成反酸发挥作用。 |
(+)-泛酸钙(Calcium(+)-Pantothenate)
CAS No. 137-08-6 C18H32CaN2O10=476.53 纯度:98.0+%(Titration)(干燥后) 可溶性溶剂:水 用途(作用):B族维生素化合物。作用于代谢反应。 |
(+)-泛酸钠(Sodium(+)-Pantothenate)
CAS No. 867-81-2 C9H16NNaO5=241.22 纯度:95.0+%(Titration) 可溶性溶剂:水 用途(作用):B族维生素化合物。作用于代谢反应。 |
◆维生素B6
盐酸吡哆醇(Pyridoxine Hydrochloride)
CAS No. 58-56-0 C8H11NO3・HCl=205.64 纯度:98.0+%(Titration) 可溶性溶剂:水 用途(作用):维生素B6化合物。 |
盐酸哆醛(Pyridoxal Hydrochloride)
CAS No. 65-22-5 C8H9NO3・HCl=203.62 纯度:98.0+%(HPLC) 可溶性溶剂:水 用途(作用):维生素B6氧化物。有维生素B6的作用。 |
吡哆醛磷酸一水合物(Pyridoxal Phosphate Monohydrate)
CAS No. 41468-25-1 C8H10NO6P・H2O=265.16 纯度:98.0+%(Absorptiometry)(干燥后) 可溶性溶剂:水 用途(作用):辅酶型维生素B6。作用于氨基酸代谢。 |
◆维生素B7
(+)-生物素((+)-Biotin)
CAS No. 58-85-5 C10H16N2O3S=244.31 纯度:97.0+%(Titration) 可溶性溶剂:氢氧化钠溶液 用途(作用):维生素B7。作为辅酶参与碳酸固定反应、羧基转移反应。 |
◆维生素B12
氰钴维生素(Cyanocobalamin)
CAS No. 68-19-9 C63H88CoN14O14P=1355.37 纯度:95.0+%(Absorptiometry)(干燥物换算) 可溶性溶剂:水 用途(作用):维生素B12化合物。参与甲基转移反应、羧基的分子内转移反应。 |
甲基维生素B12(Methylcobalamin)
CAS No. 13422-55-4 C63H91CoN13O14P=1344.38 纯度:95.0+%(HPLC) 可溶性溶剂:水 用途(作用):维生素B12化合物。参与甲基转移反应、羧基的分子内转移反应。 |
羟钴胺(Hydroxocobalamin Acetate)
CAS No. 22465-48-1 C62H89CoN13O15P・C2H4O2=1406.41 纯度:95.0+%(Absorptiometry) 用途(作用):维生素B1化合物。是参与甲基转移反应的辅酶B12。 |
◆维生素B1衍生物
盐酸呋喃硫胺(同分异构体混合物)(Fursultiamine Hydrochloride(mixture of isomers))
CAS No. 2105-43-3 C17H26N4O3S2・HCl=435.00 纯度:98.0+%(HPLC)(同分异构体混合物) 可溶性溶剂:水 保存条件:冷藏 用途(作用):维生素B1衍生物。有改善神经功能障碍作用、改善心肌代谢的作用、促进肠道运动的作用。 |
◆维生素C
L(+)-抗坏血酸(L(+)-Ascorbic Acid)
CAS No. 50-81-7 C6H8O6=176.12 純度:99.6+%(mass/mass)(Titration) 可溶性溶剂:水 用途(作用):维生素C化合物。作用于骨胶原的生物合成。 |
相关资料详情请查看:http:///pdf/show/80.html
Axygen MCT-200-A 2.0ml杂色离心管 500个/盒,10盒/箱
Axygen MCT-200-A 2.0ml杂色离心管 500个/盒,10盒/箱 1726.25
Alpha淀粉酶[米麴菌] α-Amylase (Aspergillus oryzae) 货号:E-ANAAM Megazyme中文站
Alpha淀粉酶[米麴菌]
英文名:α-Amylase (Aspergillus oryzae)
货号:E-ANAAM
规格:20000 Units
High purity alpha-Amylase (A. oryzae) for use in research, biochemical enzyme assays and in vitro diagnostic analysis.
EC 3.2.1.1
CAZy Family: GH13
From Aspergillus oryzae. Electrophoretically homogeneous.
In 3.2 M ammonium sulphate.
Specific activity: ~ 126 U/mg
Stable at 4oC for > 4 years. As used in Megazyme Starch Damage method.
暂无问题解答
暂无视频
NISSUI 日本日水培养基 06741 Compact Dry “Nissui” TC
康宁corning 3329 FILL AC,CSTACK,33CAP,MPC FEMAL 加样盖 1个/包
康宁corning 3329 FILL AC,CSTACK,33CAP,MPC FEMAL
加样盖 1个/包 4包/箱 3614.77
康宁corning 7013 PIPETTE,25ML,PW,PS,W/O PLUG,CL 移液管25ml 带塞 50个/包
康宁corning 7013 PIPETTE,25ML,PW,PS,W/O PLUG,CL
移液管25ml 带塞 50个/包 4包/箱 3854.91
活性氧化铝(Alumina, Activated)
产品编号 | 产品名称 | 产品规格 | 产品等级 | 产品价格 |
015-08297 | Alumina, Activated 活性氧化铝 |
15kg | – | – |
019-08295 | Alumina, Activated 活性氧化铝 |
500g | – | – |
活性氧化铝(Alumina, Activated)
活性氧化铝是通过水合氧化铝凝胶在300-500℃下脱水生产的。它对水和气体等具有很强的吸收能力,用作吸附剂,干燥剂和催化剂(特别是作为脱水催化剂)。
活性氧化铝分为酸性(pH 4),碱性(pH 9)和中性(pH 7.5)类型。 该产品属于碱性。
◆产品信息
活性氧化铝(Alumina, Activated) |
|
产品编号:015-08297 规格:15 kg |
产品编号:019-08295 规格:500 g |
CAS.NO:1344-28-1 分子式:Al2O3 分子量:101.96 外观:白色粉末状(参考文献:和光纯药工业株式会社信息) 溶解性:几乎不溶于水,有机溶剂,酸和碱中。(引用文献:和光纯药情报) 熔点:2030℃ 比重:3.97 |
概要·使用例 |
|
概要 |
本产品是由水合物凝胶通过300℃~500℃脱水制成的。 因为对水,气体等具有吸附能力,所以被用作吸附剂,干燥剂,催化剂(特别是脱水催化剂)。 另外,活性氧化铝分成三类,分别是酸性(pH4),碱性(pH9),中性(pH7.5)。本产品属于碱性类。 【柱色谱法用产品】【吸附色谱】【柱色谱载体】柱色谱法(column chromatography)常用于中到大规模的制备以及纯化中。 我们公司为客户提供了各种底物载体,修饰载体等多种类产品,它不仅可用于分离有机化合物,还包括天然产物,生物聚合物等。 用于吸附·反相色谱法的氧化铝载体 适用于分离中性·碱性物质,被广泛用于生物碱,类固醇,醛酮,芳香烃。 另外,吸附性载体根据其含有的水分,活性度会有显著变化。 【色谱用产品】【柱色谱载体】【用于吸附・反向色谱法的载体】【氧化铝】 氧化铝的特性 活性氧化铝因其活性具有很高的分离能力,多用于色谱法的领域中。另外,它不会与常见的溶剂发生反应,也几乎不与溶质发生反应。它的活性度会根据其水分含量发生阶段性变化,可以调节溶质的吸附能力。 氧化铝的活性度是根据偶氮染料(产品编号:012-01661 Alumina B-Tester使用)的保持能力而分成5个阶段。 (Brockmann的活性度) 以活性度I为基础,根据水分的添加,被划分为活性度II, III, IV, V的活性度(吸附能力)会逐渐降低。 活性氧化铝 Activity I种类\活性度IIIIIIIVV 酸性氧化铝0%3%6%10%15%Water addition 中性氧化铝0%3%6%10%15%Water addition 碱性氧化铝0%3%6%10%15%Water addition ※酸性氧化铝适用于分离酸性物质(酸性肽等),中性氧化铝可用于儿茶酚胺等的预处理载体。 碱性氧化铝被广泛用于生物碱,类固醇,萜等应用领域。 |
使用法 |
用于预处理的氧化铝的提纯法 儿茶酚胺分析预处理中会使用氧化铝,如果存在杂质会使儿茶酚胺的回收率降低。 我们公司为顾客提供了用于儿茶酚胺分析预处理的活性氧化铝(产品编号:018-09561) 我们介绍利用Anton&Sayre法的普通提纯法,以供参考。 操作步骤: 50g氧化铝 ↓←2N-HCl, 90℃~100℃温度下搅拌70分钟 放置后进行倾析(重复操作直至上清液呈无色透明) ↓ 放冷 ↓ 洗浄(直至PH值为4) ↓ 过滤 ↓ 干燥(110℃温度下干燥60分钟,200℃温度下干燥120分钟) ↓ 保存于干燥器中 |
用途 |
用于液相色谱柱的填充剂(引用文献:和光纯药情报) |
pH信息 |
pH(100 g/L水溶液、25℃) : 9.0~11.0(引用文献:和光纯药情报) |
Screen-Well® 离子转移谷氨酸能配体化合物库
产品编号 | 产品名称 | 产品规格 | 产品等级 | 产品价格 |
BML-2817-0500 | Screen-Well® Ionotropic Glutamatergic ligand library Screen-Well® 离子转移谷氨酸能配体化合物库 |
1 Library | – | – |
BML-2817-0100 | Screen-Well® Ionotropic Glutamatergic ligand library Screen-Well® 离子转移谷氨酸能配体化合物库 |
1 Library | – | – |
Screen-Well® 离子转移谷氨酸能配体化合物库
SCREEN-WELL® Ionotropic Glutamatergic ligand library
◆原理
SCREEN-WELL® 化合物库系列产品提供了简单,方便的方法进行化合物筛选。每个化合物库包括: 某一类化合物归为一个化合物库,包括抑制剂,激动剂或者诱导剂。 每一个化合物库提供相关文件,介绍化合物的活性,在板上的位置,物理信息还有一份结构数据(SD)文件。可单独大量提供某种化合物。
◆优点・特色
● 广泛的生产线:超过2500种小分子化合物,包括天然产物,酶抑制剂,受体的配体,药物,脂类&脂肪酸等。
独特的化合物库,包括:FDA认证化合物库、天然化合物库、化学基因组学和信号通路相关化合物等。
● 新颖性,化学物库是有相关的小分子组成,Enzo申请专利的
化合物。
● 简单低成本, 化合物全都溶在相应溶剂中、无需额外溶解
步骤,即可进行筛选。
● 包含无毒对照品,大量毒性明确且毒性不同的化合物
● 96孔板包装,溶于DMSO中,即可进行筛选
◆案例・应用
包含60种配体,包括内源性神经递质、激动剂、拮抗剂和商业化的药物。该化合物库非常适合于筛选或者识别GPCR、目标验证、第二轮筛选、确定新鉴定方法和其他药理学运用。组胺能和黑色素配体板是更大规格的神经递质化合物库(BML-2810,包括含有680种枢神经系统受体配体)的组成成分之一。
运用:高通量筛选
保存温度:-80℃
Alpha淀粉酶[猪胰腺] α-Amylase (Porcine Pancreatic) 货号:E-PANAA-3G Megazyme中文站
Alpha淀粉酶[猪胰腺]
英文名:α-Amylase (Porcine Pancreatic)
货号:E-PANAA-3G
规格:3g
High purity alpha-Amylase (Porcine Pancreatic) for use in research, biochemical enzyme assays and in vitro diagnostic analysis.
EC 3.2.1.1
CAZy Family: GH13
From porcine pancreas. Partially purified. Free flowing powder.
Specific activity: ca. 100,000 U/g (40oC, Ceralpha reagent).
Stable at -20oC for > 4 years.
For use in total dietary fiber (including resistant starch) assay procedure.
暂无问题解答
暂无视频
Megazyme总膳食纤维检测试剂盒Toal Dietary Fibre Assay Kit
上海金畔生物科技有限公司提供Megazyme总膳食纤维检测试剂盒 规格:200次检测
产品名称:膳食纤维总量检测试剂盒
英文名称:Toal Dietary Fibre Assay Kit
货号:ADM0033
型号规格:200次
优点:
使用的酶为高纯度酶,酶之间没有干扰效应的,且具有标准化酶活力。Megazyme 淀粉葡糖甘酶完全没有纤维素酶的活性,但其他公司生产的酶常被此活性污染,那样会导致β-葡聚糖被溶解和含量经常被低估。所有的Megazyme酶都是液态即用型。
应用方法:
总膳食纤维是采用经过干燥和脱脂(如果脂肪含量>10%)的复样为样品。样品用热稳定的α-淀粉酶在100℃下处理以使淀粉成胶状,水解和解聚;用蛋白酶(使蛋白溶解和解聚)和淀粉葡糖甘酶(将淀粉碎片水解成葡萄糖(来自淀粉))在60℃下处理;然后用4倍体积的乙醇处理以沉淀可溶性纤维,去除解聚的蛋白和葡萄糖(来自淀粉)。然后残留物分别用78%乙醇,95%乙醇,丙酮洗涤,再干燥,称重。一份复样用于蛋白分析,另外一份在525℃下孵育以测定灰分,总TDF就是被过滤和干燥的残留物的重量减去蛋白和灰分的重量。
适用范围:
应用于谷粒,果蔬,谷物和水果型产品食品。 酶纯度和标准化:
α-淀粉酶(E-BLAAM)的酶活为3,000UmL(Ceralpha 法);蛋白酶的浓度为50mg/mL(~350 酪氨酸U/mL);淀粉葡糖甘酶单位为200U/mL(底物为对硝基苯基β-麦芽糖苷)或单位3300U/ mL(底物为可溶性淀粉),淀粉葡糖甘酶酶活为传统TDF分析使用的150%。
更多产品,更多优惠,请联系我们!
上海金畔生物科技有限公司
订货热线:15221999938
网 址: www.jinpanbio.com
金畔博客:www.jinpanbio.cn
Email:sales@jinpanbio.com
nunc 268152 96U UNTREATED STRAIGHT W/O LID 微孔板U96 , 未处理
nunc 268152 96U UNTREATED STRAIGHT W/O LID 微孔板U96 , 未处理
和光纯药WAKO 308-93563 Phos-tag (TM) Agarose 3mL
和光纯药WAKO 308-93563 Phos-tag (TM) Agarose — –
氨[快速]检测试剂盒 Ammonia (Rapid) Assay Kit 货号:K-AMIAR Megazyme中文站
氨[快速]检测试剂盒
英文名:Ammonia (Rapid) Assay Kit
货号:K-AMIAR
规格:96 assays (manual) /960 assays (microplate
分析物意义: 常见食品的组分
Megazyme检测试剂盒优点: K-AMIAR ,反应快(3 min,室温)。
适用于手工和自动分析仪进行检测。试剂稳定
For the rapid assay of ammonia in all samples, including grape juice and wine. Content:96 assays per kit
UV-method for the determination of Ammonia in foodstuffs,
beverages and other materials
Principle:
(microbial glutamate dehydrogenase)
(1) 2-Oxoglutarate + NADPH + NH4+ → L-glutamic acid + NADP+
+ H2O
Kit size: 96 assays (manual) / 960 (microplate)
/ 960 (auto-analyser)
Method: Spectrophotometric at 340 nm
Reaction time: ~ 3 min
Detection limit: 0.07 mg/L
Application examples:
Grape juice, wine, fruit juices, soft drinks, dairy products (e.g. milk),
dietetic food, soy sauce, eggs and egg products, cheese, meat,
processed meat, seafood, bakery products (and baking agents),
fertilisers, pharmaceuticals, tobacco, cosmetics, water, Kjeldahl
analysis, paper (and cardboard), water and other materials
(e.g. biological cultures, samples, etc.)
Method recognition:
Methods based on this principle have been accepted by MEBAK
Advantages
- Very rapid reaction due to use of uninhibited glutamate dehydrogenase
- Enzyme supplied as stabilised suspension
- Very competitive price (cost per test)
- All reagents stable for > 2 years as supplied
- Mega-Calc™ software tool is available from our website for hassle-free raw data processing
- Standard included
- Extended cofactors stability
- Suitable for manual, microplate and auto-analyser formats
Q1. There is an issue with the performance of the kit; the results are not as expected.
If you suspect that the Megazyme test kit is not performing as expected such that expected results are not obtained please do the following:
- Ensure that you have tested the standard sample that is supplied with the Megazyme test kit.
- Send the results of the kit standard, blank samples and the results obtained for your sample, in the relevant MegaCalc spreadsheet (if available) to Megazyme (cs@megazyme.com). Where available the relevant MegaCalc spreadsheet can be downloaded from where the product appears on the Megazyme website.
- State the kit lot number being used (this is found on the outside of the kit box).
- State which assay format was used (refer to the relevant page in the kit booklet if necessary).
- State exact details of any modifications to the standard procedure that is provided by Megazyme.
- State the sample type and describe the sample preparation steps if applicable.
Q2. Should the pH of the sample be adjusted even for samples in acidic media?
The pH of the assay solution after the sample is added should be the same as that of the assay buffer that is supplied with the kit.
Low sample volumes (e.g. 0.1 mL) are not likely to affect the pH of the assay solution and therefore may not require pH adjustment.
Samples above 0.1 mL are more likely to affect the pH of the assay solution and therefore the pH of these samples should be adjusted as described in the data booklet, prior to addition to the assay.
Q3. Sometimes a negative absorbance change is obtained for the blank samples, is this normal? Should the real value (negative absorbance change) or “0” be used in the calculation of results?
Sometimes the addition of the last assay component can cause a small negative absorbance change in the blank samples due to a dilution effect and in such cases it is recommended that the real absorbance values be used in the calculation of results.
Q4. Is the K-AMIAR Assay Kit suitable for measurement using cell culture media samples?
Yes, assuming that the concentration of the analyte in the sample (after sample preparation) is above the limit of detection for the kit. It may be sufficient to use the sample directly in the assay after clarification by centrifugation/filtering followed by dilution (if required) in distilled water.
Q5. The pH of my sample is low (pH ~ 3.0), do I need to adjust this before I use the sample in the kit assay?
The final pH of the kit assay after the sample is added should not change from what it should be (as stated in the kit for the assay buffer). If it does change then the sample will require pH adjustment. In most cases the sample volume being used is low relative to the final assay volume and in this case the pH of the kit assay is unlikely to be affected.
Q6. How can I work out how much sample to extract and what dilution of my sample should be used in the kit assay?
Where the amount of analyte in a liquid sample is unknown, it is recommended that a range of sample dilutions are prepared with the aim of obtaining an absorbance change in the assay that is within the linear range.
Where solid samples are analysed, the weight of sample per volume of water used for sample extraction/preparation can be altered to suit, as can the dilution of the extracted sample prior to the addition of the assay, as per liquid samples.
Q7. Can you explain, step by step, how to follow the method and perform the kit assay?
For users who are not familiar with how to use the Megazyme tests kits then it is recommended that they follow this example, e.g. D-Fructose/D-Glucose Assay kit K-FRUGL (http://secure.megazyme.com/D-Fructose-D-Glucose-Assay-Kit):
1. The kit components are listed on pages 2-3 of the kit booklet.
2. Prepare the kit reagents as described on page 3.
3. For separate measurements of glucose and fructose follow procedure A on page 4.
4. Pipette the volumes listed for water, sample, solution 1 and solution 2 into 3 mL, 1 cm pathlength cuvettes. Duplicate sample assays and duplicate blanks are recommended. Mix the contents of each cuvette by inversion (seal the cuvette using parafilm or a plastic cuvette cap – do not use a finger) then after ~3 min record the first absorbance reading of each cuvette at 340 nm (this is reading A1).
5. Then add suspension 3 and mix the contents of each cuvette by inversion. Incubate for 5 minutes then record the absorbance reading of each cuvette at 340 nm (this is reading A2). NB. It is essential that the reaction is compete. To assess this, record the absorbances at ~ 2 minute intervals and until the absorbance plateaus. A stable absorbance indicates that the reaction is complete. If the absorbance continues to increase then continue to record absorbances until it plateaus and only then record absorbance reading A2.
6. Then add suspension 4 and mix the contents of each cuvette by inversion. Incubate for 5 minutes then take absorbance reading of each cuvette at 340 nm (this is reading A3). NB. As above, assess that the reaction has completed by take subsequent readings at ~2 min intervals.
7. For simple, automated results analysis, input the absorbance readings (A1, A2, A3) for samples and blanks into the K-FRUGL MegaCalc.
To ensure that the assay is working, and being performed correctly it is recommend that the test is performed using the standard sample that is provided with the kit and to obtain the expected values before proceeding to test real samples.
It is recommend that new users also watch this video which highlights how to perform the assays.
Many of the other Megazyme test kits follow a similar format.
Q8. I have some doubts about the appearance/quality of a kit component what should be done?
If there are any concerns with any kit components, the first thing to do is to test the standard sample (control sample) that is supplied with the kit and ensure that the expected value (within the accepted variation) is obtained before testing any precious samples. This must be done using the procedure provided in the kit booklet without any modifications to the procedure. If there are still doubts about the results using the standard sample in the kit then send example results in the MegaCalc spread sheet to your product supplier (Megazyme or your local Megazyme distributor).
Q9. How much sample should be used for the clarification/extraction of my sample?
The volume/weight of sample and total volume of the extract can be modified to suit the sample. This will ultimately be dictated by the amount of analyte of interest in the sample and may require empirical determination. For low levels of analyte the sample:extract volume ratio can be increased (i.e. increase the sample and/or decrease the total extraction volume).
Alternatively, for samples with low concentrations of analyte, a larger sample volume can be added to the kit assay. When altering the sample volume adjust the distilled water volume added to the assay accordingly so that the total assay volume is not altered.
Q10. Can the sensitivity of the kit assay be increased?
For samples with low concentrations of analyte the sample volume used in the kit assay can be increased to increase sensitivity. When doing this the water volume is adjusted to retain the same final assay volume. This is critical for the manual assay format because the assay volume and sample volume are used in the calculation of results.
Q11. Can the manual assay format be scaled down to a 96-well microplate format?
The majority of the Megazyme test kits are developed to work in cuvettes using the manual assay format, however the assay can be converted for use in a 96-well microplate format. To do this the assay volumes for the manual cuvette format are reduced by 10-fold. The calculation of results for the manual assay format uses a 1 cm path-length, however the path-length in the microplate is not 1 cm and therefore the MegaCalc spreadsheet or the calculation provided in the kit booklet for the manual format cannot be used for the micropalate format unless the microplate reader being used can.
There a 3 main methods for calculation of results using the microplate format:
- The easiest method is to use a microplate reader that has a path-length conversion capability (i.e. the microplater reader can detect the path-length of each well and convert the individual readings to a 1 cm path-length). This will allow values to be calculated using the MegaCalc calculation software which can be found where the product is located on the Megazyme website.
- Perform a standard curve of the analyte on each microplate that contains test samples and calculate the result of the test samples from the calibration curve (concentration of analyte versus absorbance).
- Perform a standard curve of the analyte in both the cuvette format (i.e. with a 1 cm path-length) and the 96-well microplate format and use these results to obtain a mean conversion factor between the cuvette values and the microplate values. Subsequent assays in the microplate format can then be converted from the calculated conversion factor.
Q12. Can the sensitivity of the kit assay be increased?
For samples with low concentrations of analyte the sample volume used in the kit assay can be increased to increase sensitivity. When doing this the water volume is adjusted to retain the same final assay volume. This is critical for the manual assay format because the assay volume and sample volume are used in the calculation of results.
Q13. How much sample should be used for the clarification/extraction of my sample?
The volume/weight of sample and total volume of the extract can be modified to suit the sample. This will ultimately be dictated by the amount of analyte of interest in the sample and may require empirical determination. For low levels of analyte the sample:extract volume ratio can be increased (i.e. increase the sample and/or decrease the total extraction volume).
Alternatively, for samples with low concentrations of analyte, a larger sample volume can be added to the kit assay. When altering the sample volume adjust the distilled water volume added to the assay accordingly so that the total assay volume is not altered.
Q14. When using this kit for quantitative analysis what level of accuracy and repeatability can be expected?
The test kit is extremely accurate – at Megazyme the quality control criteria for accuracy and repeatability is to be within 2% of the expected value using pure analytes.
However, the level of accuracy is obviously analyst and sample dependent.
Q15. Is it possible to add a larger volume then 2 μL of enzyme to the microplate assay? In some instances 2 μL can be difficult to pipette manually.
Yes, instead of adding 2 μL of enzyme suspension an alternative is to dilute the enzyme and add a larger volume to the microplate assay.
Dilute the assay buffer 10-fold with distilled water and use this as the diluent to dilute an aliquot of the enzyme suspension also by 10-fold. Instead of 2 μL, use 20 μL of the diluted enzyme in the microplate assay.
Q16. Can the sensitivity of the kit assay be increased?
Yes. Samples with the lower concentrations of analyte will generate a lower absorbance change. For samples with low concentrations of analyte, a larger sample volume can be used in the assay to increase the absorbance change and thereby increase sensitivity of the assay. When doing this the increased volume of the sample should be subtracted from the distilled water volume that is added to the assay so that the total assay volume is unaltered. The increase sample volume should also be accounted for when calculating final results.
Q17. Must the minimum absorbance change for a sample always be at least 0.1?
No. The 0.1 change of absorbance is only a recommendation. The lowest acceptable change in absorbance can is dictated by the analyst and equipment (i.e. pipettes and spectrophotometer) and therefore can be can be determined by the user. With accurate pipetting, absorbance changes as low as 0.02 can be used accurately.
If a change in absorbance above 0.1 is required but cannot be achieved due to low concentrations of analyte in a sample, this can be overcome by using a larger sample volume in the assay to increase the absorbance change and thereby increase sensitivity of the assay. When doing this the increased volume of the sample should be subtracted from the distilled water volume that is added to the assay so that the total assay volume is unaltered. The increase sample volume should also be accounted for when calculating final results.
康宁corning 4138 TIPS, 200UL NAT GRAD LOW BIND BARRIER IN HINGED RACKS,S,BK,960/3840 96个/盒,10盒/包
康宁corning 4138 TIPS, 200UL NAT GRAD LOW BIND BARRIER IN HINGED RACKS,S,BK,960/3840 96个/盒,10盒/包 4包/箱 3409.12
温敏性水凝胶
产品编号 | 产品名称 | 产品规格 | 产品等级 | 产品价格 |
MBG-PMW20-1001 | Mebiol ® Gel 温敏性水溶胶 |
1×10 mL | – | – |
MBG-PMW20-1005 | Mebiol ® Gel 温敏性水溶胶 |
5×10 mL | – | – |
MBG-PMW20-5001 | Mebiol ® Gel 温敏性水溶胶 |
1×50 mL | – | – |
MBG-PMW20-5005 | Mebiol ® Gel 温敏性水溶胶 |
5×50 mL | – | – |
可用于3D细胞培养和其他领域
PNIPAAm-PEG;聚N-异丙基丙烯酰胺和聚乙二醇的嵌段共聚物
水凝胶具有聚合材料的多种特征,如网络结构和高含水量,目前他广泛的运用于医药生命科学等多种领域,但不仅限于3D培养、组织工程和药物传送这些。聚N-异丙基丙烯酰胺和聚乙二醇的嵌段共聚物早在2000年初就已经商业化,研究证明,Mebiol® Gel的特性使其非常适合应用于细胞培养和组织工程。
◆原理
Mebiol® Gel温敏性水凝胶与市面上其它水凝胶的不同之处在于它可以跟随温度变化进行可逆性溶胶-凝胶转换。当温度降低时,Mebiol® Gel为溶胶状态(像液体),当温度较高时形成水凝胶。在实验操作中,该特性特别有利于进行细胞操作,比如可轻松向冷却的Mebiol® Gel中加入培养基,可通过给培养瓶降温的方式进行细胞离心收集。在凝胶状态时,Mebiol Gel的高亲脂性为细胞增殖、细胞信号转导、气体质量交换以及细胞和组织对剪切力的防御等提供了非常有效的生长环境。
◆优点、特色
●易于操作
● 无毒性,生物相容性好
● 100%合成,无病原体
● 透明度高,利于细胞观察
● 性能完善
◆案例、应用
● 干细胞和多能干细胞培养,增殖和分化
● 3D细胞培养
● 细胞移植
● 器官和组织再生
● 药物传递
● 非细胞培养应用
1. Mebiol® Gel中培养原发性肿瘤细胞
选取人肿瘤组织中的原发性肿瘤细胞进行培养该技术能够鉴定来自患者的原发性肿瘤细胞的表征,因此可根据其主要细胞化学敏感性,恶性肿瘤,转移酶活性和其它参数对患者的治疗进行评估。在胶原或者3D凝胶中培养原发性肿瘤细胞,纤维细胞的过度生长可能对其产生抑制作用。而成纤维细胞在Mebiol® Gel中不容易增殖,因此能选择性增殖原代肿瘤细胞,以便后续进一步分析鉴别。
图 1:人体癌变结肠组织Mebiol® Gel培养10天。
(提供者:Dr. S. Kubota, Dept. of General Surgery, St.Marianna University School of Medicine)
人结肠癌组织在Mebiol® Gel培养10天。只有原发性肿瘤细胞中Mebiol® Gel中增殖。
成纤维细胞在Mebiol® Gel中生长受到抑制,而在胶原蛋白和其它许多3D凝胶培养基质中,长满成纤维细胞,阻止癌细胞的增殖。
图 2:细胞生长曲线
2. 干细胞培养
猕猴胚胎干细胞用不含LIF的Mebiol® Gel培养(右图),和2D饲养层培养(左图)相比,发现形态学和碱性磷酸酶染色均未分化。
图 3
左图:2D 饲养层培养。
右图:不含LIF的3D Mebiol® Gel培养(7天)。
提供者:Dr. K. Hishikawa, Dept of Clinical Renal Regeneration, University of Tokyo.
猕猴(灵长类)胚胎干细胞在Mebiol Gel® 培养,碱性磷酸酶染色表现强阳性,表明未分化。
图 4
左图:2D 饲养层培养。
右图:不含LF的3D Mebiol® Gel培养(5天)。
3.球状体形成
Mebiol® Gel 可支持肿瘤细胞系和iPS细胞形成球体。
图 5:粘液表皮样癌(胆管癌)衍生细胞系在Mebiol® Gel中形成球状体。
(提供者: Dr. S. Kubota, Dept. of General Surgery, St. Marianna University School of Medicine)
4. 保持组织结构
Mebiol® Gel提供的环境,有利于维护组织结构在长期培养。
图 6
左图:正常结肠黏膜组织在Mebiol® Gel 中培养7天后。
右图:转移性肝癌组织在Mebiol® Gel 中培养21天后。
(提供者:Dr. S. Kubota, Dept. of General Surgery, St. Marianna University School of Medicine)
5. 体干细胞的选择性分离培养(小鼠胚胎皮肤源)
Epithelial Stem Cells from Dermis by a Three-dimensional Culture System” Journal of Cellular Biochemistry, 98 (1), 174-184 (2006)
6. 体外3-D软骨细胞培养再生软骨组织
Chondrocytes Containing Growth Factors in a Novel Thermoreversible Gelation Polymer Scaffold” Tissue Engineering, 12 (5), 1237-1245 (2006)
7. 体外3-D培养人细胞间质干细胞(hMSC)进行骨诱导
“Gene expression profile of human mesenchymal stem cells during osteogenesis in three-dimensional thermoreversible gelation polymer” Biochem. Biophys. Res. Commun., 317, 1103-1107 (2004).
8. 人类肝细胞3-D培养生产丙型肝炎病毒(HCV)
“Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b“ Virology, 351 (2), 381-392 (2006)
9. 通过局部加热进行通道控制(芯片细胞分选系统)
“On-Chip Cell Sorting System Using Laser-Induced Heating of a Thermoreversible Gelation Polymer to Control Flow”, Y. Shirasaki, J. Tanaka, H. Makazu, K. Tashiro, S. Shoji, S. Tsukita, T. Funatsu,Anal. Chem., 78, 695-701 (2006)
更多产品的相关信息查看相关单页:温敏性水凝胶
说明书 | 中文说明书 |
常见问题
◆关于Mebiol Gel的物理性能问题
Q: 当温度高于37℃(或甚至更高高达60℃),凝胶会发生什么情况?
A: 随着温度升高,凝胶会变得更硬(更凝聚)。
Q: 凝胶在2℃〜37℃是什么状态?凝胶变为溶液状态的精确温度是多少?
A: 溶胶 – 凝胶转变温度为ca.20℃
Q: 二氧化碳气体和营养物是如何提供给细胞?他们能在凝胶状态溶入细胞吗?
A: 培养基中的营养和二氧化碳可由凝胶扩散进入细胞。
Q: 当Mebiol Gel®在凝胶状态下,细胞被水凝胶包围。是否有足够的空间供细胞生长?
A: Mebiol Gel的交联点是可逆的,即使在凝胶状态(即37°C)下也一样。周边凝胶可以根据细胞的生长改变
形状而没有任何间隙/空间。
Q: 收获细胞时(溶液状态),细胞是否会发生损伤?
A: 不会
Q: 当细胞生长接触到水凝胶边缘时,是否会产生阻力?
A: 不会
Q: 可以用Mebiol Gel®来培养人肺上皮细胞吗?是否有相关研究数据?
A: 我们暂时没有相关研究数据。
Q: 在适当温度下Mebiol Gel® 从溶液转化为凝胶需要多长时间?
A: 3 msec(毫秒)
Q: 当温度在15-25℃ 时,Mebiol Gel® 是怎样一种状态?
A: 当处于转变温度时,溶液和凝胶两种状态同时存在(中间状态)。
Q: 凝胶在细胞培养条件下(37℃)的空隙有多大?
A: 非常抱歉,我们没有凝胶的孔隙率的数据,但是下面文章的讨论部分“不同的材料凝胶扩散速度”有相关
信息。
Takao et al., Novel drug delivery system using thermoreversible gelation polymer for malignant
glioma Journal of Neuro-Oncology (2005)
通常当凝胶浓度低,凝胶在材料中的“扩散速度”较高。这意味着当凝胶浓度低时,凝胶的孔隙率也较高。
然而,当凝胶浓度过低比如5%时,凝胶无法形成。
Q: 0°C-60°C是什么状态?凝胶相可逆的温度范围是?
A: 0°C-15°C: Sol溶液
15°C-20°C: 溶液和凝胶的中间状态
20°C: 溶胶-凝胶转变温度
高于 20°C: Gel凝胶
高于 37°C: 随温度升高,凝胶会变得更硬。
Q: 凝胶在37°C时的结构强度是多少??
A: 请参考以下文献。
Yoshioka H et al, A Synthetic Hydrogel with Thermoreversible Galation and Rheological Properties,
Journal of Macromolecular Science, Part A: Pure and Applied Chemistry Volume 31, Issue 1, 1994
Q: 水凝胶有孔吗?
A: 水凝胶中没有间隙和孔。
Q: 凝胶能透过CO2, N2 和 O2吗?
A: 能。
Q: 溶胶-凝胶状态可以重复转换多少次?
A: 溶胶-凝胶状态转换可以重复直到Mebiol凝胶化学分解。溶胶-凝胶重复转换的极限取决于稀释后的温度
或氧浓度。通常情况下,在冰箱能稳定存储1-2个月,长期储存,多孔板中分装的液体保持在-20°C至-80°C。
Q: 营养物分子量多少可以进入凝胶中?扩散距离与分子量的相关性是?
A: 可以在37℃通过凝胶并扩散的最大粒径分子量大约10,000-90,000(确切大小未知)。分子量的粒径数上千
如1,000-9,000,不存在通过凝胶扩散的问题,但大于此数值,则存在问题。 如果分子大小较小,扩散距离
将更长。
◆关于Mebiol Gel细胞兼容问题
Q: 当细胞在37℃生长时,我们可以更换培养基吗?
A: 37℃时,凝胶不会在水中大量溶解。因此,你可以使培养基和凝胶分层,然后更换分层后的培养基。
Q: 当Mebiol Gel®在凝胶状态下,细胞被水凝胶包围。是否有足够的空间供细胞生长?
A: Mebiol Gel的交联点是可逆的,即使在凝胶状态(即37°C)下也一样。周边凝胶可以根据细胞的生长改变
形状而没有任何间隙/空间。
Q: 凝胶适合T细胞或MSC细胞的培养吗?
A: 我们没有Mebiol gel培养T细胞的数据;关于MSC细胞,请参考以下文章:
Yuguo Lei et al., PNAS PLUS E5039–E5048 doi: 10.1073/pnas.1309408110
Q: 收获细胞时(溶液状态),细胞是否会发生损伤?
A: 不会
Q: 当细胞生长接触到水凝胶边缘时,是否会产生阻力?
A: 不会
Q: Mebiol Gel® 已成功培养的细胞有哪些?
A: 信息请见产品相关参考文献
Q: Mebiol Gel® 可用于培养肠细胞吗?有没有数据?
A: 我们暂时没有相关研究数据。
Q: Mebiol Gel® 可以用于FACS (流式细胞仪)吗?凝胶必须在哪种状态?
A: 在溶液状态下(低温),Mebiol Gel® 可以用于FACS。
Q: Mebiol Gel®可在体内使用吗?它在小鼠体内可以保留多久?
A: 可用于体内(不可用于人)。Mebiol Gel® 以凝胶形式在大鼠脑内保留超过28天。您可以参考以下文章,了解
更多信息。
T. Ozeki, K. Hashizawa, D. Kaneko, Y. Imai, H. Okada, “Treatment of rat brain tumors using
sustained-release of camptothecin from poly(lactic-co-glycolic acid) microspheres in a
thermoreversible hydrogel”, Chem. Pharm. Bull. 58 (9), 1142-1147 (2010)
Q: 可以用Mebiol Gel®来培养人肺上皮细胞吗?是否有相关研究数据?
A: 我们暂时没有相关研究数据。
Q: Mebiol Gel®会对某些细胞有毒性吗?如果有,是哪些细胞?
A: Mebiol Gel® 对细胞无毒性。
Q: 是否有Mebiol Gel® 用于甲状腺细胞(正常或肿瘤)的数据?
A: 有,请参考以下:
Production of hepatitis C viruses (HCV) by 3-D culture of human hepatocyte cell line・“Production
of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the
genome-length dicistronic viral RNA of genotype 1b“ Virology, 351 (2), 381-392 (2006)"
◆其他问题
Q: Mebiol Gel® 的有效期是多久?
A: 生产后约2年有效。
Q: 开封使用后,剩余的凝胶可保存多久?
A: 大约可保存1个月,如较长储存,需-20℃或-80℃冷冻。
Q: 我对Mebiol Gel®很感兴趣,请问能否提供样品试用?
A: 抱歉,我们无法提供Mebiol Gel®样品试用。
Q: Mebiol Gel® 如何消毒?在凝胶内可能存在生物活体吗?
A: 通过EOG杀菌。在凝胶中不会有任何生物体。
Q: 10ml 和 50ml的Mebiol Gel® 产品需要使用何种规格的培养瓶?
A: 分别用T-25 和 T-75 培养瓶
Q: 我可以用20%凝胶浓度代替10%储存吗?我需要将它用于不同类型的培养基。
A: 可以用20%凝胶浓度代替10%储存。但是,请注意,20%的高浓度下,即使是低温,凝胶粘性也非常高,并
具有低流动性。
Q: Mebiol Gel® (MBG-PMW20-1001) 可溶于10ml 培养基,它可以溶于更大体积的培养基吗?
A: 我们建议您将10 ml规格的Mebiol Gel® 溶于10 ml培养基中。(同样,使用50 ml规格的Mebiol Gel® 需溶
于50 ml培养基)如果您Mebiol Gel® 溶液浓度太低,可能无法形成凝胶状态。比如,如果将10 ml规格
Mebiol Gel® 溶于20 ml培养基,则无法形成胶凝。
Q: 每只Mebiol Gel® 含有多少g产品?
A: 10ml规格, 含 1.0g Mebiol Gel;50ml 规格,含5.0g Mebiol Gel。
Q: 对于5g(50ml)/瓶的包装,我想将它分成更小的规格,需要如何操作?我不希望用任何的培养基溶解后再
分装,只想分装PNIPAAm-PEG本身。然后用不同的培养基溶解分装后的试剂。
A: 理想的情况是将Mebiol Gel®在液态下等分,并保存于冰箱中(-80℃)。用普通溶剂(如PBS)溶解
Mebiol Gel® #MBG-PMW20-5005 (5g),然后进行分装。并保存在冰箱中。请准备5x浓度的培养基其他
成分,按照4:1比例添加到分装的Mebiol Gel中。
Q: Mebiol Gel粉末能在室温中保存吗?
A: 能。Mebiol Gel粉末可在室温中保存。
Q: 粉色片剂是什么?
A: 氧气检测剂。与Mebiol Gel®一同能提供氧气和水分吸收。它们不是产品的一部分。
细胞培养和组织再生
研究领域 |
Publication |
Pubmed ID (PMID) |
干细胞(人类多能干细胞 (hPSC)增殖和分化) |
A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Lei Y, Schaffer DV. Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):E5039-48. doi: 10.1073/pnas.1309408110. Epub 2013 Nov 18.PMID: 24248365 |
24248365 |
干细胞(人类多能干细胞(HPSC)线扩建和分化) |
An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem Cells. |
28057917 |
干细胞(角膜缘),综述 |
Towards the use of hydrogels in the treatment of limbal stem cell deficiency Bernice Wright, Shengli Mi, Che J. Connon Drug Discovery Today, Volume 18, Issues 12, January 2013, Pages 79-86 a |
22846850 |
细胞培养(肾囊肿的形成) |
Mxi1 influences cyst formation in three-dimensional cell culture. YJ Yook, KH Yoo, SA Song, MJ Seo, JY Ko, BH Kim, EJ Lee, E Chang, YM Woo, and JH Park BMB Rep, Mar 2012; 45(3): 189-93. |
22449707 |
基于细胞的ROS测定 |
Determination of Chronic Inflammatory States in Cancer Patients Using Assay of Reactive Oxygen Species Production by Neutrophils Yoko Suzuki, Satoshi Ohno, Ryuji Okuyama, Atsushi Aruga, Masakazu Yamamoto, Shigeki Miura, Hiroshi Yoshioka, Yuichi Mori, And Katsuhiko Suzuki Anticancer Res, Feb 2012; 32: 565 – 570.ROS Cell-Based Assay |
22287746 |
基于细胞的ROS测定 |
Effect of Green Tea Extract on Reactive Oxygen Species Produced by Neutrophils from Cancer Patients Katsuhiko Suzuki, Satoshi Ohno, Yoko Suzuki, Yumiko Ohno, Ryuji Okuyama, Atsushi Aruga, Masakazu Yamamoto, Ken-O Ishihara, Tsutomu Nozaki, Shigeki Miura, Hiroshi Yoshioka, And Yuichi Mori Anticancer Res, Jun 2012; 32: 2369 – 2375. |
22641677 |
生物工艺 |
Light-Patterned RNA Interference of 3D-Cultured Human Embryonic Stem Cells. |
27787919 |
胶质母细胞瘤的抽搐药物发现 |
Scalable Production of Glioblastoma Tumor-initiating Cells in 3 Dimension Thermoreversible Hydrogels. |
27549983 |
骨桥蛋白的生产 |
A CD153+CD4+ T Follicular Cell Population with Cell-Senescence Features Plays a Crucial Role in Lupus Pathogenesis via Osteopontin Production |
25972477 |
干细胞(人类多能干细胞 (hPSC)增殖和分化) |
Developing Defined and Scalable 3D Culture Systems for Culturing Human Pluripotent Stem Cells at High Densities. |
25419247 |
干细胞培养,再生医学 |
Application of a Thermo-Reversible Gelation Polymer, Mebiol Gel, for Stem Cell Culture and Regenerative Medicine Kataoka K and Huh N*Journal of Stem Cell & Regenerative Medicine 2010 Vol. 6(1): p10-14 (2010) |
link |
器官培养 |
FGF signaling directs a center-to-pole expansion of tubulogenesis in mouse testis differentiation. Hiramatsu R, Harikae K, Tsunekawa N, Kurohmaru M, Matsuo I, Kanai Y. Development. 2010 Jan;137(2):303-12. doi: 10.1242/dev.040519. |
20040496 |
干细胞(角膜缘) |
Ex vivo cultivation of corneal limbal epithelial cells in a thermoreversible polymer (Mebiol Gel) and their transplantation in rabbits: an animal model. G Sitalakshmi, B Sudha, HN Madhavan, S Vinay, S Krishnakumar, Y Mori, H Yoshioka, and S Abraham Tissue Eng Part A, Feb 2009; 15(2): 407-15. |
18724830 |
干细胞(角膜缘) |
Limbal Stem Cells: Application in Ocular Biomedicine Review Article Geeta K. Vemuganti, Anees Fatima, Soundarya Lakshmi Madhira, Surendra Basti, Virender S. Sangwan International Review of Cell and Molecular Biology, Volume 275, 2009, Pages 133-181 |
19491055 |
病毒感染/复制系统 |
3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV Hussein Hassan Aly, Kunitada Shimotohno, Makoto Hijikata Biochemical and Biophysical Research Communications, Volume379, Issue 2, 6 February 2009, Pages 330-334 |
19103167 |
胚胎移植培养 |
Antagonism between Smad1 and Smad2 signaling determines the site of distal visceral endoderm formation in the mouse embryo.Yamamoto M, Beppu H, Takaoka K, Meno C, Li E, Miyazono K, Hamada H. J Cell Biol. 2009 Jan 26;184(2):323-34. doi: 10.1083/jcb.200808044. Epub 2009 Jan 19. |
19153222 |
肝细胞移植 |
Intraperitoneal Transplantation Of Hepatocytes Embedded In Thermoreversible Gelation Polymer (Mebiol Gel) In Acute Liver Failure Rat Model. N. Parveen, A.A. Khan, S. Baskar, M.A. Habeeb, P. Ravindra Babu, A. Samuel, Y. Hiroshi, M. Yuichi, C.M. Habibullah Hepatitis Monthly, Volume 275 8, Issue 4, Autumn, November 2008 Page S71 |
link |
干细胞(间充质) |
Chrondrogenic differentiation of human mesenchymal stem cells from umbilical cord blood in chemicially synthesized thermoreversible polymer. Kao, I, et al. Chinese J. Physiology, 51(4), 252-258 (2008) |
19112883 |
肝细胞培养 |
Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. Hussein H. Aly, Koichi Watashi, Makoto Hijikata, Hiroyasu Kaneko, Yasutugu Takada, Hiroto Egawa, Shinji Uemoto, Kunitada Shimotohno Journal of Hepatology, Volume 46, Issue 1, January 2007, Pages 26-36 |
17112629 |
干细胞(角膜缘) |
Cultivation of human corneal limbal stem cells in Mebiol gel–A thermo-reversible gelation polymer. B Sudha, HN Madhavan, G Sitalakshmi, J Malathi, S Krishnakumar, Y Mori, H Yoshioka, and S Abraham Indian J Med Res, Dec 2006; 124(6): 655-64 |
17287553 |
组织工程(骨) |
In vitro culture of chondrocytes in a novel thermoreversible gelation polymer scaffold containing growth factors. Yasuda A, Kojima K, Tinsley KW, Yoshioka H, Mori Y, Vacanti CA. Tissue Eng. 2006 May;12(5):1237-45. |
16771637 |
干细胞(上皮) |
Isolation of epithelial stem cells from dermis by a three-dimensional culture system. Medina RJ, Kataoka K, Takaishi M, Miyazaki M, Huh NH. J Cell Biochem. 2006 May 1;98(1):174-84. |
16408300 |
干细胞(角膜缘) |
Comparative Study on Growth Characteristics of Cadaveric Human Corneal Limbal Stem Cells in Mebiol Gel (a Synthetic Polymer) and on Human Amniotic Membrane. H.N. Madhavan, B. Sudha1, G. Sitalakshmi, S. KrishnaKumar, Y. Mori, H. Yoshioka and S. Abraham.Invest Ophthalmol Vis Sci 2006;47: E-Abstract 3033. 3033B186 |
|
组织再生(肝) |
Thermoreversible gelation polymer induces the emergence of hepatic stem cells in the partially injured rat liver. Nagaya M, Kubota S, Suzuki N, Akashi K, Mitaka T.Hepatology. 2006 May;43(5):1053-62. |
16628635 |
病毒增殖和药物筛选 |
Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b.Murakami K, Ishii K, Ishihara Y, Yoshizaki S, Tanaka K, Gotoh Y, Aizaki H, Kohara M, Yoshioka H, Mori Y, Manabe N, Shoji I, Sata T, Bartenschlager R, Matsuura Y, Miyamura T, Suzuki T.Virology. 2006 Aug 1;351(2):381-92. Epub 2006 May 6. |
16678876 |
胚胎培养 |
Canonical Wnt Signaling and Its Antagonist Regulate Anterior-Posterior Axis Polarization by Guiding Cell Migration in Mouse Visceral Endoderm. Chiharu Kimura-Yoshida, Hiroshi Nakano, Daiji Okamura, Kazuki Nakao, Shigenobu Yonemura, Jose A. Belo, Shinichi Aizawa, Yasuhisa Matsui, Isao Matsuo Developmental Cell, Volume 9, Issue 5, November 2005, Pages 639-650 |
16256739 |
细胞在Mebiol Gel中的生长评估 |
H.N. Madhavan, J. Malathi, Patricia Rinku Joseph, Mori Yuichi, Samuel JK Abraham and Hiroshi Yoshioka. A study on the growth of continuous culture cell lines embedded in Mebiol Gel., Current Science, 87(9), 1275~77(2004). |
|
干细胞培养和分化 |
Gene expression profile of human mesenchymal stem cells during osteogenesis in three-dimensional thermoreversible gelation polymer. Hishikawa K, Miura S, Marumo T, Yoshioka H, Mori Y, Takato T, Fujita T. Biochem Biophys Res Commun. 2004 May 14;317(4):1103-7. |
15094382 |
肝再生 |
Evaluation of Thermoreversible gelation polymer for Regeneration of Focal Liver Injury. M. Nagaya, S. Kubota, N. Suzuki, M. Tadakoro, K. Akashi. Eur Surg Res, 36:95-103 (2004). |
15007262 |
球状培养(肿瘤) |
S. Tsukikawa, H. Matsuoka, Y. Kurahashi, Y. Konno, K. Satoh, R. Satoh, A. Isogai, K. Kimura, Y. Watanabe, S. Nakano, J. Hayashi, and S. Kubota. A new method to prepare multicellular spheroids in cancer cell lines using a thermo-reversible gelation polymer, Artifcial Organs, 27(7), 598 -604(2003). |
12823414 |
伤口康复 |
Wound Dressing of Newly Developed Thermo gelling Thermo reversible Hydro gel. H. Yoshioka, Y. Mori, S. Kubota , Jpn J Artif Organs, 27(2), 503 -506 (1998).(Japanese Publication- Abstract in English) |
|
胰岛移植 |
In Vitro Studies on a New Method for Islet Micro encapsulation Using a Thermo reversible Gelation Polymer, N-Isopropylacrylamide-Based Copolymer. S. Shimizu, M. Yamazaki, S. Kubota, T. Ozasa, H. Moriya, K. Kobayashi, M. Mikami, Y. Mori and S. Yamaguchi. Artif Organs, Vol. 20, No.11 (1996). |
8908335 |
Mebiol Gel应用——非细胞培养
研究领域 |
Publication |
Pubmed ID (PMID) |
蛋白质结晶支架 |
A Novel Approach for Protein Crystallization by a Synthetic Hydrogel with Thermoreversible Gelation Polymer. Sugiyama, et al., Cryst. Growth Des., 2013, 13(5), pp 1899-1904 |
link |
DNA电泳和修复支架 |
Separation and recovery of DNA fragments by electrophoresis through a thermoreversible hydrogel composed of poly (ethylene oxide) and poly (propylene oxide). Yoshioka H, Mori Y, Shimizu M. Anal Biochem. 2003 Dec 15;323(2):218-23. |
14656528 |
细胞分选 |
On-chip cell sorting system using laser-induced heating of a thermoreversible gelation polymer to control flow. Shirasaki Y, Tanaka J, Makazu H, Tashiro K, Shoji S, Tsukita S, Funatsu T. Anal Chem. 2006 Feb 1;78(3):695-701. |
16448041 |
细胞分选 |
Microfluidic cell sorter with flow switching triggered by a solgel transition of a thermo-reversible gelation polymer.Kazuto Ozaki, Hirokazu Sugino, Yoshitaka Shirasaki, Tokihiko Aoki, Takahiro Arakawa, Takashi Funatsu, Shuichi Shoji Sensors and Actuators B: Chemical, Volume 150, Issue 1, 21 September 2010, Pages 449-455 |
link |
DNA分子分选 |
Microfluidic active sorting of DNA molecules labeled with single quantum dots using flow switching by a hydrogel solgel transition. Mai Haneoka, Yoshitaka Shirasaki, Hirokazu Sugino, Tokihiko Aoki, Takahiro Arakawa, Kazuto Ozaki, Dong Hyun Yoon, Noriyuki Ishii, Ryo Iizuka, Shuichi Shoji, Takashi FunatsuSensors and Actuators B: Chemical, Volume 159, Issue 1, 28 November 2011, Pages 314-320 |
link |
药物输送 |
Novel drug delivery system using thermoreversible gelation polymer for malignant glioma.Arai T, Joki T, Akiyama M, Agawa M, Mori Y, Yoshioka H, Abe T. J Neurooncol. 2006 Mar;77(1):9-15. |
16292493 |
药物输送 |
Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes.Arai T, Benny O, Joki T, Menon LG, Machluf M, Abe T, Carroll RS, Black PM.Anticancer Res. 2010 Apr;30(4):1057-64. |
20530409 |
细胞分选开关 |
On-Chip Cell Sorting System Using Thermoreversible Gelation Polymer. |
|
细胞培养药物筛选 |
Alternatives to Animal Testing and Experimentation Wakui et al. in vitro Thermoreversible Gel Disc Quantitative Assay of Rat Angiogenesis. AATEX16(2), 59-65, 2011 |
link |
Mebiol Gel 物理特性
研究领域 |
Publication |
Pubmed ID (PMID) |
物理特性 |
A synthetic hydrogel with thermoreversible gelation. II. : Effect of added salts. H. Yoshioka, M. Mikami, Y. Mori, and E. Tsuchida. J. Macromol. Sci., A31(1), 121-125 (1994). |
link |
物理特性 |
Thermoreversible gelation on heating and on cooling of an aqueous gelatin-poly(N-isopropylacrylamide) conjugate. , H. Yoshioka, Y. Mori, S. Tsukikawa, and S. Kubota, Polym. Adv. Tech., 9, 155-158 (1998). |
link |
物理特性 |
A Synthetic hydrogel with thermoreversible gelation. I. Preparation and rheological properties , H. Yoshioka, M. Mikami and Y. Mori. J.M.S- Pure Appl. Chem., A31(1), pp. 113-120 (1994). |
link |
物理特性 |
Preparation of Poly (N-Isopropylacrylamide)-b-Poly(Ethylene Glycol) and Calorimetric Analysis of its Aqueous Solution , H. Yoshioka, M. Mikami and Y. Mori,J.M.S- Pure Appl. Chem., A31(1), pp. 109-112 (1994). |
link |
物理特性 |
Endovascular treatment of experimental aneurysms using a combination of thermoreversible gelation polymer and protection devices: feasibility study. |
19687707 |
物理特性 |
Bio rapid prototyping by extruding/aspirating/refilling thermoreversible hydrogel. |
20811123 |
物理特性 |
A synthetic hydrogel with thermoreversible gelation. III. : An NMR study of the Sol-Gel transition. H. Yoshioka, Y. Mori and James A. Cushman. Polym. Adv. Tech., 5, pp. 122-127 (1994). |
link |
电泳仪
产品编号 | 产品名称 | 产品规格 | 产品等级 | 产品价格 |
CBJ-IMR2-001 | iMyRun II 电泳仪 |
见本页 | – | – |
CBJ-IMR2-201 | i-MyRun II 电源 |
1 SET | ||
CBJ-IMR2-221 | i-MyRun II 电源线 |
1 PC | ||
CBJ-IMR2-311 | i-MyRun II 盖板 |
1 PC | ||
CBJ-IMR2-401 | i-MyRun II 制胶系统(制胶托盘、制胶台、制胶梳子) |
1 SET | ||
CBJ-IMR2-411 | i-MyRun II 制胶托盘 |
1 PC | ||
CBJ-IMR-421-EX | i-MyRun II / N 制胶台 |
1 PC | ||
CBJ-IMR-431-EX | i-MyRun II / N 制胶梳 |
6 PC |
电泳仪
i-MyRun II
◆原理
物质分子在正常情况下一般不带电,即所带正负电荷量相等,故不显示带电性。但是在一点的物理作用或化学反应条件下,某些物质分子会成为带电的离子(或粒子),不同的物质,由于其带电性质、颗粒形状和大小不同,因而在一定的电场中它们的移动方向和移动速度也不同,因此可使它们分离。
MyRun II的电泳槽不仅仅是凝胶托盘,同时也是紫外线可通透的。甚至在运行时,利用蓝光LED照明器和合适的染色剂,电泳的状态可通过UV透照器直接观察。整合了的电源和电泳槽为您的使用带来了很多的安全。
因此我们自信地向您推荐这款创新设计,物超所值的产品!
◆产品规格
电源 |
|
尺寸 |
219(W) × 90(L) × 62(H) mm |
输出电压 |
DC 50,75,100,120,135 V |
输入电压 |
AC 100~240 V 50/60 Hz |
时间设定 |
0~99 min (by minute) |
电泳槽 |
|
格式 |
高通量(可泳动156个样品) |
上样形式 |
可使用8或12通道移液枪 |
盖板设计 |
带开缝的迁移拱形盖板 |
迁移距离 |
1.8 cm 或2.75 cm 在高通量情况下 |
上样规格 |
9 μL(26 well)或18 μL(13 well) |
尺寸 |
160(W)×212(L)×58(H) mm |
制胶系统 |
|
凝胶尺寸 |
124(W) × 120(L) mm |
上样量 |
26 well,9 μL 13 well,18 μL |
最大样本数 |
26 well × 6 rows = 156 个样品 |
◆优点・特色
● 不仅仅是凝胶托盘,电泳槽对紫外线(UV)和蓝光LED光同样具有通透性。
● 利用124x120 mm的凝胶可电泳8~156 份样品。(适用于8或12 根多种吸液管)
● 传统的小凝胶也可使用。(凹凸部分设计在电泳内部)
● 0~99 分钟的时间设定或不限时运行。
● 5 种可选电压(50, 75, 100, 120, 135 V)
● 只要电泳期间外盖被打开,电源便自动切断,保障安全。
● 简易结合/分离的电源和电泳槽。
● 盖子上带有重视凝胶可视性和散热性的细缝。
● 控制面板为防水设计。
用户友好的界面。通过简单的触摸操作调节电压。
可选择电压:50, 75, 100, 120 or 135 V。
可选择时间:0-99 分钟或不限时运行。
更高效:一次最大泳动样品数:156
电泳槽也有支持小凝胶的格栅。
更安全:自在和带有盖子的电泳槽相连接的情
况下,电源才会启动。
更方便:如图,只需向上抬起一定高度,电源
即可轻松地与电泳槽分离。
◆案例・应用
● 适合分离大片段的DNA
● 可以提取大分子DNA
● PCR产物在琼脂糖凝胶上的电泳检测
i-MyRun II 电泳仪
产品编号 |
产品名称 |
包装 |
CBJ-IMR2-001 |
i-MyRun II电泳仪 |
1 unit |
组成部件:
● 电泳槽 | ● 电源 | ● 制胶系统 |
● 电泳槽盖板 | ● 电源线 | ● 电泳梳(6个) |
● 说明手册 |
※产品规格见相关资料
i-MyRun II部件与附件
产品编号 |
产品名称 |
包装 |
CBJ-IMR2-201 |
i-MyRun II电源 |
1 SET |
CBJ-IMR2-221 |
i-MyRun II电源线 |
1 PC |
CBJ-IMR2-301 |
i-MyRun II电泳槽和盖板 |
1 SET |
CBJ-IMR2-311 |
i-MyRun II盖板 |
1 PC |
CBJ-IMR2-401 |
i-MyRun II制胶系统(制胶托盘、制胶台、制胶梳子) |
1 SET |
CBJ-IMR2-411 |
i-MyRun II制胶托盘 |
1 PC |
CBJ-IMR-421-EX |
i-MyRun II/N制胶台 |
1 PC |
CBJ-IMR-431-EX |
i-MyRun II/N制胶梳 |
6 PC |
i-MyRun II 附件(小凝胶)
产品编号 |
产品名称 |
包装 |
CBJ-IMR-403-EX |
i-MyRun II/NC制胶系统(制胶托盘L/S、制胶台、制胶梳子) |
1 SET |
CBJ-IMR-413-EX |
i-MyRun II/NC制胶托盘(Lx2) |
1 SET |
CBJ-IMR-414-EX |
i-MyRun II/NC制胶托盘(Sx4) |
1 SET |
CBJ-IMR-423-EX |
i-MyRun II/NC制胶台 |
1 SET |
CBJ-IMR-433-EX |
i-MyRun II/NC制胶梳 |
2 PC |
电泳槽规格
外径尺寸 |
160(W)× 212(L)× 58(H)mm |
可于电泳槽上设置的凝胶种类及个数 |
124×120 mm凝胶・・・・・・・・・・1个 |
紫外线等的穿透性 |
无论电泳槽和凝胶托盘的哪部分都具有紫外线穿透性 (也具有蓝色LED光穿透性) |
盖板设计 |
盖板加入重视散热性和分辨性的缝隙 |
样品应用
使用的凝胶 |
124×120 mm |
凝胶尺寸 |
124(W)× 120(L)mm |
可在i-MyRun II中设置的凝胶个数 |
1个 |
可应用的样品数 |
当使用26个格栅的电泳梳时:最多156个样品(6列) |
对应的多通道移液器 |
适用于8节或12节的通道移液器 |
样品容量 |
当使用26个格栅的电泳梳时:9μL/格栅 当使用13个格栅的电泳梳时:18μL/格栅 |
泳动的距离 |
制作凝胶的托盘中,当设置等间隔的电泳梳数量为: i-MyRun II 凝胶铸造系统(单件购买商品号:IMR2-401) |
样品应用(小凝胶)
使用的凝胶 |
小凝胶(L) |
小凝胶(S) |
凝胶尺寸 |
107(W)×60(L)mm |
52(W)×60(L)mm |
可在i-MyRun II中设置的凝胶个数 |
最多2个 |
最多4个 |
可应用的样品数 |
最多50个样品(25格栅×2个)或是最多34个样品(17格栅×2个) |
最多48个样品(12格栅×4个)或是最多32个样品(8格栅×4个) |
电力供应规格
对应安全性 |
・电泳槽与电源之间装载有确认连接的开关 |
定时器 |
0~99分钟 |
外径尺寸 |
219(W)× 90(L)× 68(H)mm |
电源 |
50, 75, 100, 120, 135V |
输入电压 |
AC100~240V 50/60Hz |
点击图片进入
常见问题
Q1: 产品接口地方接触到液体,是否会造成短路?
A2: 如果液体进入到接口的孔洞里,虽然里面有一定的保护装置,但因为里面有各种电子元件,也可能会造成短
路。如果接头接触到了液体,请尽快擦拭,防止腐蚀。请参考手册前4页的注意事项。
Q2: 这个电泳槽是UV通透的,如果去拍照的话,需要将电泳槽上方的盖子去掉吗?
A2: 因为盖子也是UV通透的,所以不需要去掉。而且iMyRun II可以在电泳运行的同时,进行实时观察。
Q3: 拍照的时候,如果把整个电泳槽放入凝胶成像系统,要不要倒掉电泳槽里面的电泳缓冲液?
A3: 不需要。
Q4: 样品电泳距离在1.8 cm以上,可以一次性电泳156样品吗?
A4: 影响电泳的因素很多,比如电压,时间,样本片段大小,凝胶的浓度,buffer的状态等等都会影响到电泳
速度(距离)。
如果您的样本长度均一,只考虑是否发现(阴性或阳性)的话,改变凝胶浓度,还是可以一次性跑大量样本的。
例如,利用限制性核酸内切酶处理的Genotyping实验,只需要判断特定长度的片段是否存在。
具体的电泳条件,需要您根据自己的实验进行优化调节。
一般来说,琼脂糖凝胶的浓度和它能分辨的DNA片段长度范围可以参考下图。
Axygen P-DW-11-C 1.1ml圆孔深孔板 5块/包,10包/箱
Axygen P-DW-11-C 1.1ml圆孔深孔板 5块/包,10包/箱 2328.04
L-谷氨酸[谷氨酸盐/谷氨酸酯/味精/谷氨酸单钠]检测试剂盒 L-Glutamic Acid Assay Kit 货号:K-GLUT Megazyme中文站
L-谷氨酸[谷氨酸盐/谷氨酸酯/味精/谷氨酸单钠]检测试剂盒
英文名:L-Glutamic Acid Assay Kit
货号:K-GLUT
规格:60 assays (manual) /
分析物意义:常见的天然食品组分,例如在奶酪和番茄中或调味剂中,如味精
Megazyme检测试剂盒优点:提供的硫辛酰胺脱氢酶是稳定的悬浮液而不是可溶性粉末,从而减少了酶的浪费
The L-Glutamic Acid test kit is a simple, reliable, rapid and accurate method for the measurement and analysis of L-glutamate (MSG) in foodstuffs.
Suitable for manual, auto-analyser and microplate formats.
Colourimetric method for the determination of L-Glutamic Acid
(Monosodium Glutamate; MSG) in foodstuffs and other materials
Principle:
(beef liver glutamate dehydrogenase)
(1) L-Glutamic acid + NAD+ + H2O ↔ 2-oxoglutarate + NADH + NH4+
(diaphorase)
(2) INT + NADH + H+ → NAD+ + INT-formazan
Kit size: 60 assays (manual) / 600 (microplate)
/ 700 (auto-analyser)
Method: Spectrophotometric at 492 nm
Reaction time: ~ 9 min
Detection limit: 0.21 mg/L
Application examples:
Fruit and vegetables (e.g. tomato), processed fruit and vegetables
(e.g. tomato puree / juice, ketchup, soy sauce), condiments, processed
meat products (e.g. extracts, bouillon and sausages), soup, pharmaceuticals
and other materials (e.g. biological cultures, samples, etc.)
Method recognition:
Methods based on this principle have been accepted by ISO, GOST
and NMKL
Advantages
- Very competitive price (cost per test)
- All reagents stable for > 2 years after preparation
- Glutamate dehydrogenase solution stable at -20°C
- No wasted diaphorase solution (stable suspension supplied)
- Rapid reaction
- Mega-Calc™ software tool is available from our website for hassle-free raw data processing
- Standard included
- Suitable for manual, microplate and auto-analyser formats
Q1. What level of cysteine in test samples will affect the results obtained from K-GLUT?
Samples that contain cysteine levels higher than 1 mM will not generate results within the required specification for the K-GLUT assay.
Q2. Should the pH of the sample be adjusted even for samples in acidic media?
The pH of the assay solution after the sample is added should be the same as that of the assay buffer that is supplied with the kit.
Low sample volumes (e.g. 0.1 mL) are not likely to affect the pH of the assay solution and therefore may not require pH adjustment.
Samples above 0.1 mL are more likely to affect the pH of the assay solution and therefore the pH of these samples should be adjusted as described in the data booklet, prior to addition to the assay.
Q3. There is an issue with the performance of the kit; the results are not as expected.
If you suspect that the Megazyme test kit is not performing as expected such that expected results are not obtained please do the following:
- Ensure that you have tested the standard sample that is supplied with the Megazyme test kit.
- Send the results of the kit standard, blank samples and the results obtained for your sample, in the relevant MegaCalc spreadsheet (if available) to Megazyme (cs@megazyme.com). Where available the relevant MegaCalc spreadsheet can be downloaded from where the product appears on the Megazyme website.
- State the kit lot number being used (this is found on the outside of the kit box).
- State which assay format was used (refer to the relevant page in the kit booklet if necessary).
- State exact details of any modifications to the standard procedure that is provided by Megazyme.
- State the sample type and describe the sample preparation steps if applicable.
Q4. How can I work out how much sample to extract and what dilution of my sample should be used in the kit assay?
Where the amount of analyte in a liquid sample is unknown, it is recommended that a range of sample dilutions are prepared with the aim of obtaining an absorbance change in the assay that is within the linear range.
Where solid samples are analysed, the weight of sample per volume of water used for sample extraction/preparation can be altered to suit, as can the dilution of the extracted sample prior to the addition of the assay, as per liquid samples.
Q5. I have some doubts about the appearance/quality of a kit component what should be done?
If there are any concerns with any kit components, the first thing to do is to test the standard sample (control sample) that is supplied with the kit and ensure that the expected value (within the accepted variation) is obtained before testing any precious samples. This must be done using the procedure provided in the kit booklet without any modifications to the procedure. If there are still doubts about the results using the standard sample in the kit then send example results in the MegaCalc spread sheet to your product supplier (Megazyme or your local Megazyme distributor).
Q6. Can the sensitivity of the kit assay be increased?
For samples with low concentrations of analyte the sample volume used in the kit assay can be increased to increase sensitivity. When doing this the water volume is adjusted to retain the same final assay volume. This is critical for the manual assay format because the assay volume and sample volume are used in the calculation of results.
Q7. How much sample should be used for the clarification/extraction of my sample?
The volume/weight of sample and total volume of the extract can be modified to suit the sample. This will ultimately be dictated by the amount of analyte of interest in the sample and may require empirical determination. For low levels of analyte the sample:extract volume ratio can be increased (i.e. increase the sample and/or decrease the total extraction volume).
Alternatively, for samples with low concentrations of analyte, a larger sample volume can be added to the kit assay. When altering the sample volume adjust the distilled water volume added to the assay accordingly so that the total assay volume is not altered.
Q8. Can the test kit be used to measure biological fluids and what sample preparation method should be used?
The kit assay may work for biological fluids assuming that inositol is present above the limit of detection for the kit after any sample preparation (if required). Centrifugation of the samples and use of the supernatant directly in the kit assay (with appropriate dilution in distilled water) may be sufficient. However, if required a more stringent sample preparation method may be required and examples are provided at the following link:http://www.megazyme.com/docs/analytical-applications-downloads/biological_samples_111109.pdf?sfvrsn=2
The test kit has not been tested using biological fluids as samples because it is not marketed or registered as a medical device. This will therefore require your own validation.
Q9. Can the manual assay format be scaled down to a 96-well microplate format?
The majority of the Megazyme test kits are developed to work in cuvettes using the manual assay format, however the assay can be converted for use in a 96-well microplate format. To do this the assay volumes for the manual cuvette format are reduced by 10-fold. The calculation of results for the manual assay format uses a 1 cm path-length, however the path-length in the microplate is not 1 cm and therefore the MegaCalc spreadsheet or the calculation provided in the kit booklet for the manual format cannot be used for the micropalate format unless the microplate reader being used can.
There a 3 main methods for calculation of results using the microplate format:
- The easiest method is to use a microplate reader that has a path-length conversion capability (i.e. the microplater reader can detect the path-length of each well and convert the individual readings to a 1 cm path-length). This will allow values to be calculated using the MegaCalc calculation software which can be found where the product is located on the Megazyme website.
- Perform a standard curve of the analyte on each microplate that contains test samples and calculate the result of the test samples from the calibration curve (concentration of analyte versus absorbance).
- Perform a standard curve of the analyte in both the cuvette format (i.e. with a 1 cm path-length) and the 96-well microplate format and use these results to obtain a mean conversion factor between the cuvette values and the microplate values. Subsequent assays in the microplate format can then be converted from the calculated conversion factor.
Q10. When using this kit for quantitative analysis what level of accuracy and repeatability can be expected?
The test kit is extremely accurate – at Megazyme the quality control criteria for accuracy and repeatability is to be within 2% of the expected value using pure analytes.
However, the level of accuracy is obviously analyst and sample dependent.
Q11. Absorbance values of my sample reactions continue to increase slowly after the reaction should be complete. Is there an explanation for this?
Some samples can react with the INT in the assay and cause a non-enzymatic creep reaction.
The 3rd worksheet in the MegaCalc is used to account for any creep reaction in your results.
Q12. Must the minimum absorbance change for a sample always be at least 0.1?
No. The 0.1 change of absorbance is only a recommendation. The lowest acceptable change in absorbance can is dictated by the analyst and equipment (i.e. pipettes and spectrophotometer) and therefore can be can be determined by the user. With accurate pipetting, absorbance changes as low as 0.02 can be used accurately.
If a change in absorbance above 0.1 is required but cannot be achieved due to low concentrations of analyte in a sample, this can be overcome by using a larger sample volume in the assay to increase the absorbance change and thereby increase sensitivity of the assay. When doing this the increased volume of the sample should be subtracted from the distilled water volume that is added to the assay so that the total assay volume is unaltered. The increase sample volume should also be accounted for when calculating final results.
Q13. Can the sensitivity of the kit assay be increased?
Yes. Samples with the lower concentrations of analyte will generate a lower absorbance change. For samples with low concentrations of analyte, a larger sample volume can be used in the assay to increase the absorbance change and thereby increase sensitivity of the assay. When doing this the increased volume of the sample should be subtracted from the distilled water volume that is added to the assay so that the total assay volume is unaltered. The increase sample volume should also be accounted for when calculating final results.
hPSC解离溶液
产品编号 | 产品名称 | 产品规格 | 产品等级 | 产品价格 |
160-27051 | hPSC Dissociation Solution | 100ml | 细胞培养用 | - |
197-17571 | StemSure hPSC Medium Δ | 100ml | 细胞培养用 | - |
193-17573 | StemSure hPSC Medium Δ | 100ml×4 | 细胞培养用 | - |
064-05381 | Fibroblast Growth Factor (basic), Human, recombinant,Animal-derived-free【bFGF/FGF2】 | 50μg | 细胞生物学用 | - |
068-05384 | Fibroblast Growth Factor (basic), Human, recombinant,Animal-derived-free【bFGF/FGF2】 | 100μg | 细胞生物学用 | - |
060-05383 | Fibroblast Growth Factor (basic), Human, recombinant,Animal-derived-free【bFGF/FGF2】 | 1mg | 细胞生物学用 | - |
257-00511 | Y-27632 | 1mg | 细胞生物学用 | - |
253-00513 | Y-27632 | 5mg | 细胞生物学用 | - |
251-00514 | Y-27632 | 25mg | 细胞生物学用 | - |
253-00591 | 5 mmol/L Y-27632 Solution | 300μl | 细胞培养用 | - |
220-02041 | Vitronectin(20-398 aa), Human, recombinant, Solution | 500μg | 生化学用 | - |
197-16275 | StemSure D-MEM (High Glucose) with Phenol Red and Sodium Pyruvate | 500ml | 细胞培养用 | - |
197-16775 | StemSure Serum Replacement (SSR) | 500ml | 细胞培养用 | - |
198-15781 | StemSure 10 mmol/L 2-Mercaptoethanol Solution ( x 100) | 100ml | 细胞培养用 | - |
195-15791 | StemSure 50 mmol/L Monothioglycerol Solution ( x 100) | 100ml | 细胞培养用 | - |
190-15805 | StemSure(R) 0.1w/v% Gelatin Solution | 500ml | 细胞培养用 | - |
199-16051 | StemSureR LIF, Mouse, recombinant, Solution | 106units | 细胞培养用 | - |
195-16053 | StemSureR LIF, Mouse, recombinant, Solution | 106units×10 | 细胞培养用 | - |
195-16031 | StemSure Freezing Medium | 100ml | 细胞培养用 | - |
hPSC解离溶液
人多功能干细胞用细胞分散溶液 提供评价用样本!
本品是在无饲养层培养条件下培养人ES/iPS继代细胞是使用的细胞分散溶液,不含动物或者人类来源物质,也未使用胰蛋白酶和胶原酶等酶。请与StemSure® hPSC培养基Δ结合使用。另外,Wako还准备了评价用样本(10ml),如有需要,请填写表格申请。
◆特点
●无饲养层培养用
●不含酶
●无动物来源成分
●添加有Y-27632可用于单细胞继代培养
◆测试项目
●无菌测试
●pH
●渗透压
●内毒素
●支原体测试
◆使用方法
<在使用6孔板时>
-
清除培养基,用D-PBS(-)清洗细胞
-
清除D-PBS(-),将1ml/well本品加进孔板
-
7℃,5%CO2条件下,培养5分钟
-
敲击剥离细胞群
-
加入2ml/well的ROCKi+培养基,通过移液枪吹散细胞群为单细胞。
(ROCKi+培养基:指在人iPS细胞用培养基中加入Y-27632,使最终浓度变为10μmol/l的培养基。)
-
将分散液移至离心管,室温下1,000rpm离心3分钟。
-
去除上清。
-
继代培养时,添加2ml/wellROCKi+培养基,悬浮,种植。
-
冻存时,用StemSure®冻存液悬浮,分装到保存用离心管,冻存。
〔使用注意事项〕
由于细胞种类和涂层剂的不同,会使培养容器中的细胞粘着性有所不同,,用hPSC解离溶液处理至敲击能使细胞剥离。
◆人iPS细胞的细胞分散
StemSure® hPSC培养基Δ培养的人iOS细胞201B7株,添加hPSC解离溶液,观察细胞的解离状态。添加hPSC解离溶液5分钟后敲击,移液枪吹散细胞为单细胞。
◆人iPS细胞的继代
用StemSure® hPSC培养基Δ和hPSC解离溶液对iPS细胞201B7株进行继代培养,细胞增殖能力可到6继代后,各种未分化Marker(Oct3/4, Nanog, rBC2LCN)的表达呈阳性。
《 細胞増殖能力 》
〔細胞株〕
人iPS细胞201B7株
〔培养基组份〕
StemSure® hPSC培养基Δ + 35ng/ml bFGF
〔涂层剂〕
Matrigel® hESC-Qualified Matrix
〔细胞种植数〕
1.0×105 cells/well (使用6孔板)
《未分化性维持》
相关产品
★液体培养基・细胞培养用试剂★
Wako提供液体培养基、平衡盐溶液、细胞剥离·分散溶液、抗生物质溶液、细胞外基质等丰富的产品种类。
★ES・iPS细胞研究用试剂★
2007年,建立iPS细胞的消息发布之后,与iPS细胞相关的许多文章相继发表。在这些发表的文章中,也罗列了与ES细胞·iPS细胞未分化能维持、分化诱导相关的低分子化合物。
★LIF, 人, 重组人体, 培养上清★
LIF具有抑制小鼠ES细胞分化的作用,因此在细胞培养时,它可用于维持ES细胞的未分化状态。
★rBC2LCN★
rBC2LCN可识别人ES细胞·人iPS细胞。通过加入含有人ES细胞·人iPS细胞的营养液,可给未分化细胞活体染色。
乳果糖检测试剂盒 Lactulose Assay Kit 货号:K-LACTUL Megazyme中文站
乳果糖检测试剂盒
英文名:Lactulose Assay Kit
货号:K-LACTUL
规格:50 assays
Megazyme乳果糖检测试剂盒采用酶法分析原理,可定量检测鲜奶、UHT奶、浓缩乳和奶粉等各种乳品中的乳果糖。与农业部新标准采用相同的检测原理和方法该试剂盒采用ISO方法11285:2004,经过改进后,更加快速和灵敏灵敏度是传统己糖激酶法的两倍成本低试剂配制后可稳定保存2年采用试剂盒形式,包含检测必需的所有酶提供计算软件,使数据处理更方便包含标准品
The Lactulose Assay Kit is suitable for the specific, rapid and sensitive measurement and analysis of lactulose in milk and milk-based samples. Reagents included in this kit may also be prepared for use in the procedure described by ISO Method 11285:2004.
UV-method for the determination of Lactulose in milk and
foodstuffs containing dairy products
Principle:
(β-galactosidase)
(1) Lactulose + H2O → D-galactose + D-fructose
(glucose oxidase + catalase + H2O2)
(2) D-Glucose + H2O + O2 → D-gluconic acid + H2O2
(hexokinase)
(3) D-Fructose + ATP → F-6-P + ADP
(phosphoglucose isomerase)
(4) F-6-P → G-6-P
(glucose-6-phosphate dehydrogenase)
(5) G-6-P + NADP+ → gluconate-6-phosphate + NADPH + H+
(gluconate-6-phosphate dehydrogenase)
(6) Gluconate-6-phosphate + NADP+ → ribulose-5-phosphate + NADPH
+ CO2 + H+
Kit size: 50 assays
Method: Spectrophotometric at 340 nm
Reaction time: ~ 120 min
Detection limit: 4.8 mg/L
Application examples:
Milk, dairy products and foods containing milk
Method recognition: Novel method
Advantages
- Twice the sensitivity of traditional hexokinase based lactulose methods
- Very cost effective
- All reagents stable for > 2 years after preparation
- Mega-Calc™ software tool is available from our website for hassle-free raw data processing
- Standard included
Q1. Sometimes a negative absorbance change is obtained for the blank samples, is this normal? Should the real value (negative absorbance change) or “0” be used in the calculation of results?
Sometimes the addition of the last assay component can cause a small negative absorbance change in the blank samples due to a dilution effect and in such cases it is recommended that the real absorbance values be used in the calculation of results.
Q2. Some samples generate values of A2 – A1 greater than 0.3?
Samples that generate absorbance values A2 – A1 of 0.3 should be diluted in distilled water prior to the Sample Preparation (section A, page 7) and the second incubation of step 2 increased (glucose oxidase / catalase) to 30 min.
Q3. What are the critical steps of the K-LACTUL assay kit?
Some critical steps of the assay are as follows:
A2 should be read after approximately 10 min and you should ensure that the reaction has finished, i.e. measure the absorbance until it stops increasing. (Slight increases in absorbance of 0.001/min or less are acceptable).
The supernatants from both steps (1 and 2) of A. Sample Preparation should be clear.
Q4. Can the K-LACTUL kit be used to measure samples other than milk-based samples?
The K-LACTUL kit will measure lactulose in most samples however it is the sample preparation prior to the Enzymatic Determination Reaction that is important. Megazyme has only tested milk-based samples, however most samples that do not contain high protein levels may work using the same standard procedure as described in the K-LACTUL data booklet. Samples containing very high levels of free fructose may not work.
Q5. Should the pH of the sample be adjusted even for samples in acidic media?
The pH of the assay solution after the sample is added should be the same as that of the assay buffer that is supplied with the kit.
Low sample volumes (e.g. 0.1 mL) are not likely to affect the pH of the assay solution and therefore may not require pH adjustment.
Samples above 0.1 mL are more likely to affect the pH of the assay solution and therefore the pH of these samples should be adjusted as described in the data booklet, prior to addition to the assay.
Q6. There is an issue with the performance of the kit; the results are not as expected.
If you suspect that the Megazyme test kit is not performing as expected such that expected results are not obtained please do the following:
- Ensure that you have tested the standard sample that is supplied with the Megazyme test kit.
- Send the results of the kit standard, blank samples and the results obtained for your sample, in the relevant MegaCalc spreadsheet (if available) to Megazyme (cs@megazyme.com). Where available the relevant MegaCalc spreadsheet can be downloaded from where the product appears on the Megazyme website.
- State the kit lot number being used (this is found on the outside of the kit box).
- State which assay format was used (refer to the relevant page in the kit booklet if necessary).
- State exact details of any modifications to the standard procedure that is provided by Megazyme.
- State the sample type and describe the sample preparation steps if applicable.
Q7. Is it possible to check where issues in the measurement of lactulose may be occurring?
If it is suspected that the measurements of K-LACTUL are not correct and there is doubt regarding the performance of the kit then the following steps should be checked.
1. Check that the cuvettes are 1.5 mL microcuvettes and that the volume of the liquid in the cuvettes is high enough for the spectrophotometer.
2. Check the temperature of the reactions is correct.
Using the standard lactulose/fructose solution (bottle 8) that is supplied with the kit will help determine where issues are occurring with the measurement of lactulose samples. The obvious steps where issues may occur are: A. Sample Preparation (page 7 K-LACTUL booklet) and B. Enzymatic Determination Reaction (page 8 K-LACTUL booklet).
3. The performance of K-LACTUL can be tested as follows:
(A. Sample Preparation (page 7 K-LACTUL booklet)
Use 0.5 mL of the standard lactulose /fructose solution (Bottle 8) which contains 0.1 mg/mL lactulose and 0.05 mg/mL fructose. The typical individual absorbance values are: A1 = 0.2, A2 = 0.2, A3 = 1.0. This should generate a final absorbance difference of (A3-A2) of approximately 0.8 (Note: this measurement includes the lactulose and fructose measurement and is not just lactulose content only).
Note: If the correct values are obtained for the performance of K-LACTUL then there is no need to check the performance of the Enzymatic Determination Reaction step separately.
4. The performance of the Enzymatic Determination Reaction step can be tested separately as follows:
B. Enzymatic Determination Reaction (page 8 K-LACTUL booklet)
This test uses 0.1 mL of the standard lactulose /fructose solution (Bottle 8) which contains 0.05 mg/mL fructose. This is equivalent to 5 μg of fructose added to the cuvette and should generate an absorbance difference (A3-A2) of approximately 0.3. If this absorbance difference is obtained then it can be concluded that the step is performing correctly.
B. ENZYMATIC DETERMINATION REACTION:
Wavelength: 340 nm
Cuvette: 1 cm light path (glass or plastic; 1.5 mL semi-micro)
Final volume: 1.16 mL
Sample solution: 0.65-65 μg of lactulose per cuvette (in 0.1-1.0 mL sample volume)
Read against air (without cuvette in the light path) or against water Pipette
Pipette into cuvettes |
Sample |
Blank |
standard 8 (lactulose/fructose solution) distilled water solution 3 (imidazole buffer) solution 4 (NADP+/ATP) |
0.10 mL 0.90 mL 0.05 mL 0.05 mL |
– 1.00 mL 0.05 mL 0.05 mL |
Mix*, read absorbance of the solutions (A1) after approx. 3 min and start the reactions by addition of: |
||
suspension 5 (HK/G-6-PDH) suspension 6 (6-PGDH) |
0.02 mL 0.02 mL |
0.02 mL 0.02 mL |
Mix*, read absorbance of the solutions (A2) at the end of the reaction (approx. 10 min). Then add: |
||
suspension 7 (PGI) |
0.02 mL |
0.02 mL |
Mix*, read absorbance of the solutions (A3) at the end of the reaction (approx. 15 min). |
* for example with a plastic spatula or by gentle inversion after sealing the cuvette with a cuvette cap or Parafilm®.
Q8. How can I work out how much sample to extract and what dilution of my sample should be used in the kit assay?
Where the amount of analyte in a liquid sample is unknown, it is recommended that a range of sample dilutions are prepared with the aim of obtaining an absorbance change in the assay that is within the linear range.
Where solid samples are analysed, the weight of sample per volume of water used for sample extraction/preparation can be altered to suit, as can the dilution of the extracted sample prior to the addition of the assay, as per liquid samples.
Q9. I have some doubts about the appearance/quality of a kit component what should be done?
If there are any concerns with any kit components, the first thing to do is to test the standard sample (control sample) that is supplied with the kit and ensure that the expected value (within the accepted variation) is obtained before testing any precious samples. This must be done using the procedure provided in the kit booklet without any modifications to the procedure. If there are still doubts about the results using the standard sample in the kit then send example results in the MegaCalc spread sheet to your product supplier (Megazyme or your local Megazyme distributor).
Q10. Can the sensitivity of the kit assay be increased?
For samples with low concentrations of analyte the sample volume used in the kit assay can be increased to increase sensitivity. When doing this the water volume is adjusted to retain the same final assay volume. This is critical for the manual assay format because the assay volume and sample volume are used in the calculation of results.
Q11. Can the test kit be used to measure biological fluids and what sample preparation method should be used?
The kit assay may work for biological fluids assuming that inositol is present above the limit of detection for the kit after any sample preparation (if required). Centrifugation of the samples and use of the supernatant directly in the kit assay (with appropriate dilution in distilled water) may be sufficient. However, if required a more stringent sample preparation method may be required and examples are provided at the following link:http://www.megazyme.com/docs/analytical-applications-downloads/biological_samples_111109.pdf?sfvrsn=2
The test kit has not been tested using biological fluids as samples because it is not marketed or registered as a medical device. This will therefore require your own validation.
Q12. Can the manual assay format be scaled down to a 96-well microplate format?
The majority of the Megazyme test kits are developed to work in cuvettes using the manual assay format, however the assay can be converted for use in a 96-well microplate format. To do this the assay volumes for the manual cuvette format are reduced by 10-fold. The calculation of results for the manual assay format uses a 1 cm path-length, however the path-length in the microplate is not 1 cm and therefore the MegaCalc spreadsheet or the calculation provided in the kit booklet for the manual format cannot be used for the micropalate format unless the microplate reader being used can.
There a 3 main methods for calculation of results using the microplate format:
- The easiest method is to use a microplate reader that has a path-length conversion capability (i.e. the microplater reader can detect the path-length of each well and convert the individual readings to a 1 cm path-length). This will allow values to be calculated using the MegaCalc calculation software which can be found where the product is located on the Megazyme website.
- Perform a standard curve of the analyte on each microplate that contains test samples and calculate the result of the test samples from the calibration curve (concentration of analyte versus absorbance).
- Perform a standard curve of the analyte in both the cuvette format (i.e. with a 1 cm path-length) and the 96-well microplate format and use these results to obtain a mean conversion factor between the cuvette values and the microplate values. Subsequent assays in the microplate format can then be converted from the calculated conversion factor.
Q13. How much sample should be used for the clarification/extraction of my sample?
The volume/weight of sample and total volume of the extract can be modified to suit the sample. This will ultimately be dictated by the amount of analyte of interest in the sample and may require empirical determination. For low levels of analyte the sample:extract volume ratio can be increased (i.e. increase the sample and/or decrease the total extraction volume).
Alternatively, for samples with low concentrations of analyte, a larger sample volume can be added to the kit assay. When altering the sample volume adjust the distilled water volume added to the assay accordingly so that the total assay volume is not altered.
Q14. When using this kit for quantitative analysis what level of accuracy and repeatability can be expected?
The test kit is extremely accurate – at Megazyme the quality control criteria for accuracy and repeatability is to be within 2% of the expected value using pure analytes.
However, the level of accuracy is obviously analyst and sample dependent.
Q16. Can the sensitivity of the kit assay be increased?
Yes. Samples with the lower concentrations of analyte will generate a lower absorbance change. For samples with low concentrations of analyte, a larger sample volume can be used in the assay to increase the absorbance change and thereby increase sensitivity of the assay. When doing this the increased volume of the sample should be subtracted from the distilled water volume that is added to the assay so that the total assay volume is unaltered. The increase sample volume should also be accounted for when calculating final results.
Q15. Must the minimum absorbance change for a sample always be at least 0.1?
No. The 0.1 change of absorbance is only a recommendation. The lowest acceptable change in absorbance can is dictated by the analyst and equipment (i.e. pipettes and spectrophotometer) and therefore can be can be determined by the user. With accurate pipetting, absorbance changes as low as 0.02 can be used accurately.
If a change in absorbance above 0.1 is required but cannot be achieved due to low concentrations of analyte in a sample, this can be overcome by using a larger sample volume in the assay to increase the absorbance change and thereby increase sensitivity of the assay. When doing this the increased volume of the sample should be subtracted from the distilled water volume that is added to the assay so that the total assay volume is unaltered. The increase sample volume should also be accounted for when calculating final results.
上海金畔生物科技有限公司提供修饰性PEG分子量清单
PEG修饰剂 活化聚乙二醇 修饰性聚乙二醇:
mPEG-NH2 MW 350
mPEG-NH2 MW 550
mPEG-NH2 MW 750
mPEG-NH2 MW 1000
mPEG-NH2 MW 2000
mPEG-NH2 MW 5000
mPEG-COOH MW 1000
mPEG-COOH MW 2000
mPEG-COOH MW 5000
mPEG-SH MW 1000
mPEG-SH MW 2000
mPEG-SH MW 5000
mPEG-SPA MW 1000
mPEG-SPA MW 2000
mPEG-SPA MW 5000
mPEG-Mal MW 5000
mPEG-ALD MW 2000
mPEG-ALD MW 5000
mPEG-SCM MW 1000
mPEG-SCM MW 2000
mPEG-SCM MW 5000
mPEG-Hydrazide MW 2000
mPEG-Hydrazide MW 5000
mPEG-DSPE MW 2000
mPEG-Silane MW 2000
NH2-PEG-NH2 MW 300
NH2-PEG-NH2 MW 600
NH2-PEG-NH2 MW 1000
NH2-PEG-NH2 MW 2000
NH2-PEG-NH2 MW 3400
NH2-PEG-NH2 MW 4000
COOH-PEG-COOH MW 1000
COOH-PEG-COOH MW 2000
MAL-PEG-MAL MW 2000
MAL-PEG-MAL MW 4000
NHS-PEG-NHS MW 3400
NH2-PEG-COOH MW 1000
NH2-PEG-COOH MW 2000
NH2-PEG-COOH MW 3400
NH2-PEG-COOH MW 4000
NH2-PEG-OH MW 1000
NH2-PEG-OH MW 2000
NH2-PEG-OH MW 4000
NH2-PEG-SH MW 4000
BOC-NH-PEG-SC MW 5000
BOC-NH-PEG-OH MW 2000
BOC-NH-PEG-NH2 MW 3400
BOC-NH-PEG-NHS MW 2000
Fmoc-NH-PEG-COOH MW 2000
Fmoc-NH-PEG-NHS MW 2000
Biotin-PEG-NH2 MW 3400
Biotin-PEG-NHS MW 2000
Biotin-PEG-SCM MW 4000
Biotin-PEG-OH MW 4000
HO-PEG-COOH MW 2000
Mal-PEG-NHS MW 3400
Mal-PEG-OH MW 2000
Mal-PEG-COOH MW 2000
Folate-PEG-NH2 MW 3400
DSPE-PEG-Mal MW 2000
SH-PEG-SH MW 3400
SH-PEG-COOH MW 3400
NPC-PEG-NPC MW 3400
FITC-PEG-NH2 MW 3400
4-arm-PEG-COOH MW 10000
4-arm-PEG-NH2 MW 10000
4-arm-PEG-SH MW 10000
mPEG-OH MW 2000
mPEG-OH MW 5000
mPEG-OH MW 20000
康宁corning 431155 FLTR SYS,150ML,.45UM,CA,S,IND, 真空过滤系统 150ml 0.45umCA(醋酸纤维)膜 50mm直径 灭菌 单个包装9(cf 430516) 1个/包
康宁corning 431155 FLTR SYS,150ML,.45UM,CA,S,IND,
真空过滤系统 150ml 0.45umCA(醋酸纤维)膜 50mm直径 灭菌 单个包装9(cf 430516) 1个/包 12包/箱 1250.93
和光纯药WAKO 169-09125 Polyethylene Glycol 6,000 500g
和光纯药WAKO 169-09125 Polyethylene Glycol 6,000 Wako 1st Grade 25322-68-3
康宁corning 3897BC PLATE,96WL,VB,PS,W/GENERIC BARCODE,WO/LID,NS,BK,25/100 25个/包
康宁corning 3897BC PLATE,96WL,VB,PS,W/GENERIC BARCODE,WO/LID,NS,BK,25/100 25个/包 4包/箱 3512.97
NUNC 159625 5 ML PIPETTE SI. INDIVIDUAL WRAP 血清移液管,总容量,5ml
NUNC 159625 5 ML PIPETTE SI. INDIVIDUAL WRAP 血清移液管,总容量,5ml
丙酮酸激酶(兔肌) Pyruvate kinase (rabbit muscle) 货号:E-PKRM Megazyme中文站
丙酮酸激酶(兔肌)
英文名:Pyruvate kinase (rabbit muscle)
货号:E-PKRM
规格:5,000 Units at 37°C
High purity pyruvate kinase (rabbit muscle) for use in research, biochemical enzyme assays and in vitro diagnostic analysis.
EC 2.7.1.40
CAS: 9001-59-6
ATP:pyruvate 2-O-phosphotransferase
From rabbit muscle.
In 3.2 M ammonium sulphate.
Supplied at ~ 2,500 U/mL.
Specific activity: 233 U/mg protein at pH 7.2 and 37oC.
Stability: > 2 years 4oC.
暂无问题解答
暂无视频
α-葡萄糖苷酶(嗜热脂肪芽孢杆菌)(重组) α-Glucosidase (Bacillus stearothermophilus) (Recombinant) 货号:E-TSAGS Megazyme中文站
α-葡萄糖苷酶(嗜热脂肪芽孢杆菌)(重组)
英文名:α-Glucosidase (Bacillus stearothermophilus) (Recombinant)
货号:E-TSAGS
规格:3000 Units at 40°C /6000 Units at 60°C
Alpha葡[萄]糖苷酶[嗜热脂肪芽孢杆菌]
EC 3.2.1.20
CAZY Family: GH13
Recombinant from Bacillus stearothermophilus. In 3.2 M ammonium sulphate.
Specific activity: ~ 280 U/mg (60oC, pH 6.5 on p-nitrophenyl-α-D-glucopyranoside); ~ 135 U/mg (40oC, pH 6.5 on p-nitrophenyl-α-D-glucopyranoside).
Action on other substrates: Blocked p-nitrophenol maltoheptaoside < 0.0001 %
Stability: > 4 years at 4oC.
暂无问题解答
暂无视频